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Abstract 
 
 
Yeasts of the genus Candida are important human pathogens. A new species, Candida bracarensis 
was recently described revealing phenotypic and genetic similarities with Candida glabrata, a 
widespread pathogen, and also with Saccharomyces cerevisiae. The incidence of C. bracarensis 
has increased globally being now regarded as an emergent fungal pathogen. However, little is 
known about its characteristics as a pathogenic agent and the interaction with its host. The aim of 
this work was to compare C. bracarensis with C. glabrata and S. cerevisiae concerning their 
interaction with the host. We observed that C. glabrata was phagocytosed at higher rates than C. 
bracarensis by murine and human macrophages, but both species similarly stimulated the 
production of reactive oxygen species (ROS). S. cerevisiae induced the lowest phagocytosis rate 
and production of ROS. Other differences observed were a higher content of (1,3)-linked glucose, 
which is related with the content in β-1,3-glucans, in C. bracarensis cell wall. In accordance, C. 
bracarensis yeasts stained with an anti-β-1,3-glucan monoclonal antibody showed a significantly 
brighter signal than C. glabrata and S. cerevisiae, as assessed by flow cytometry and confocal 
microscopy. Moreover, C. bracarensis showed the highest percentage of relative cell wall porosity, 
as evaluated by using DEAE-dextran/poly-L-lysine polycations. Additionally, increased levels of the 
proinflammatory cytokines IL-12, TNF-α, IL-1β, and IL-23 were generally detected in the culture 
supernatants of murine bone marrow-derived dendritic cells (BMDCs) and macrophages (BMMs) 
stimulated with C. bracarensis as compared to cultures incubated with the other two yeast species. 
The recognition of the former yeast species by Dectin-1 would thus be in agreement with the 
observed increased IL-23 and also TNF-α production. Indeed, anti-Dectin-1 blockage significantly 
decreased the levels of TNF-α in both BMDCs and BMMs stimulated with C. bracarensis, but not 
with C. glabrata and S. cerevisiae, implicating this pattern recognition receptor in C. bracarensis 
regonition and signaling. Considering all the above results we hypothesize that C. bracarensis cell 
wall higher porosity might account for higher accessibility to β-1,3-glucans thereby facilitating yeast 
recognition by the C-type lectin Dectin-1, resulting in the induction of a strong response by the host 
immune system that could contribute to a faster elimination of this pathogen. Although these 
results do not by themselves fully elucidate the disparate incidence of C. glabrata vs C. 
bracarensis, they nevertheless contribute to better understand the differences on the interaction of 
these two related species with the host. 
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Resumo 
 
 
As leveduras do género Candida são importantes agentes patogénicos em infeções fúngicas 
humanas. Recentemente foi descrita uma nova espécie, Candida bracarensis, que se assemelha 
tanto fenotípica como genotipicamente com Candida glabrata e também com Saccharomyces 
cerevisiae. A incidência desta nova espécie tem vindo a aumentar, estando entre os fungos 
considerados emergentes. Contudo, muito pouco se conhece acerca das suas características 
como patogéneo e sobre a sua interação com o hospedeiro. Assim, o objetivo deste projeto foi 
comparar C. bracarensis, C. glabrata e S. cerevisiae no que diz respeito aos mecanismos de 
interação com o hospedeiro. C. glabrata foi mais fagocitada do que C. bracarensis por macrófagos 
humanos e de ratinho. No entanto, ambas as espécies estimularam semelhante produção de 
espécies reactivas de oxigénio (ROS). S. cerevisiae foi a espécie menos fagocitada e a que 
estimulou menor produção de ROS. Foi ainda observado que a parede celular de C. bracarensis 
era constituída por um elevado teor de β-1,3-glucanas, o que está de acordo com o sinal 
significativamente mais intenso das células de C. bracarensis, em comparação com as de C. 
glabrata e S. cerevisiae, quando marcadas com um anticorpo anti-β-1,3-glucanas e analisadas por 
citometria de fluxo e por microscopia confocal. C. bracarensis foi também a espécie que 
apresentou a maior percentagem relativa de porosidade da parede celular, determinada por um 
ensaio com os poli-catiões DEAE-dextrano e poli-L-lisina. Adicionalmente, os níveis de citocinas pro-
inflamatórias IL-12, TNF-α, IL-1β, e IL-23 nos sobrenadantes de culturas de células dendríticas e 
de macrófagos de ratinho derivados da medula óssea foram mais elevados quando infetados com 
C. bracarensis do que com as outras duas espécies de levedura. O reconhecimento de C. 
bracarensis pelo receptor Dectin-1 poderá explicar a elevada produção de IL-23 e TNF-α induzida 
por esta espécie. De facto, o bloqueio de Dectin-1 levou a uma marcada redução dos níveis de 
TNF-α em resposta a C. bracarensis, salientando o impacto deste receptor no reconhecimento 
desta espécie e na posterior sinalização. Coloca-se assim como hipótese que a elevada porosidade 
da parede celular de C. bracarensis possa permitir uma maior acessibilidade aos β-1,3-glucanas e 
facilitar o seu reconhecimento pela lectina Dectin-1, o que poderia contribuir para uma eliminação 
mais rápida e eficiente deste agente patogénico. Ainda que estes resultados não expliquem por si 
só a disparidade encontrada na incidência de C. glabrata e C. bracarensis, contribuem no entanto 
para um melhor conhecimento da interação destas duas espécies com o hospedeiro.  
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Chapter 1 
General Introduction !!!!!!!!!!!!!!!!!!!!!
!!2!
!!
  
 ! 3!
1. Fungal infections: characterization and clinical importance!
 
Fungi represent a large, diverse and widespread group of heterotrophic eukaryotes. These 
organisms are very proficient at sensing their surrounding and responding to signals that promote 
their survival in changing environments. Furthermore, they can interact with plants, animals or 
humans in multiple ways, establishing symbiotic, commensal, latent or pathogenic relationships 
(Madigan et al., 2011).  As a result, in the last decades, human fungal infections incidence has 
risen especially in immunocompromised and hospitalized individuals. The morbidity and mortality 
associated with these infections are substantial, and it is clear that fungal diseases have emerged 
as important public health problems. McNeil et al., (2001) analyzed  the trends in infectious 
disease mortality in the United States and found a dramatic increase in multiple-cause mortality 
due to mycoses, from 1557 deaths in 1980 to 6534 deaths in 1997. The majority of the mycose-
related deaths are associated with Candida, Aspergillus, and Cryptococcus infection (Krcmery and 
Barnes, 2002; Pfaller and Diekema, 2007; Silva et al., 2012). There are several possible reasons 
for the elevated incidence of systemic fungal infections: i) an important one might be the increase 
in lifespan in the populations of the developed world and the age related loss of immune-
competence; ii) an increase of systemic fungal infections was probably also due to more intensive 
treatment schemes for haematological and oncological patients causing prolonged neutropenic 
phases; iii) finally, more effective antibacterial treatments allow patients with infections to survive 
longer without necessarily overcoming the underlying diseases and thus leaving them susceptible 
to other opportunistic infections (Pfaller and Diekema, 2007; Sardi et al., 2013). 
Of the fungi regarded as human pathogens, the members of the genus Candida are the most 
frequently recovered from human fungal infections. The genus Candida contains over 150 
heterogeneous species, but only a minority has been implicated in human candidiasis. Of the 
Candida species isolated from humans, Candida albicans is the most prevalent under both healthy 
and disease conditions. However, Candida glabrata, Candida tropicalis, Candida krusei and 
Candida parapsilosis are involved in pathogenic episodes too, and the number of infections due to 
non-albicans Candida species has increased significantly (Krcmery and Barnes, 2002; Mayer et al., 
2013). !!!
!!4!
2.  Candida infections: overview  !
Candida species belong to the normal microbiota of an individual’s mucosal oral cavity, 
gastrointestinal and genitourinary tracts but, under certain circunstances, can be responsible for 
various clinical manifestations from mucocutaneous overgrowth to bloodstream infections 
(Sampaio et al. 2010; Gow and Hube, 2012; Wang et al., 2014).  Transition from colonization to 
mucosal and/or systemic infection is partly explained by modern medical progress, relying on 
large-spectrum antibiotics, immunosuppressive chemotherapy, and devices such as catheters, all 
of which have been shown to predispose to invasive candidiasis (Gabaldón et al., 2013). In order to 
cause infection, the opportunistic pathogens need to invade different host sites, evade the immune 
system, and survive and reproduce within the host. Furthermore, in systemic infections, they 
spread to new tissues and organs (Yang, 2003; Haynes, 2001; Silva et al., 2012).  
 
2.1 Candida glabrata and its related species Candida bracarensis  !
In the last decades, the number of infections due to C. glabrata has increased considerably 
(Rodrigues et al., 2014). Historically, C. glabrata has always been referred to as a non-pathogenic 
yeast from the normal saprophytic flora of healthy subjects and rarely were described severe 
infections caused by this species in humans (Fidel et al., 1999; Brieland et al., 2001; Kaur et al., 
2005). However, due to the widespread and increasing use of immunosuppressive agents, in 
conjunction with the implementation of broad-spectrum antimycotic therapy, the frequency of 
mucosal and systemic infections caused by C. glabrata increased significantly, making it the 
second or third most common cause of candidiasis (Kullberg and Arendrup, 2015). C. glabrata is 
able to colonize commensally the mouth, esophagus, intestines, and vagina mucosal surfaces, but 
still little is known about its interaction with the host and which are the protective host defence 
mechanisms. It is expected that host mechanisms control C. glabrata, by suppressing the 
expression of its pathogenic properties, thus preventing infection (Kramer et al., 2006; Roetzer et 
al., 2011). C. glabrata is haploid and presents a yeast form. Until now, episodes of hyphae 
formation in C. glabrata have not been described and, hardly ever, formation of pseudohyphae was 
observed (Csank and Haynes 2000; Jandric and Schuller 2011; Brunke and Hube 2013). 
Compared to other Candida species, C. glabrata appears to be one of the most vigorous, being 
able to survive on inanimate surfaces for more than 5 months, while the viability of C. albicans is 
limited to 4 months and C. parapsilosis cells die after 2 weeks in similar conditions (Kramer et al., 
 ! 5!
2006; Roetzer et al., 2011). The genome of C. glabrata type strain (CBS138T/American Type 
Culture Collection, ATCC 2001T), was sequenced and despite its name, this yeast is 
phylogenetically closer to the model yeast Saccharomyces cerevisiae than to C. albicans, and is 
part of the Saccharomycetaceae family (Figure 1) (Fidel et al., 1999; Dujon et al., 2004; Gabaldón 
et al., 2013). C. glabrata shares a common ancestral with several Saccharomyces species, but has 
lost many more genes during evolution than S. cerevisiae from their common ancestor. These 
changes in C. glabrata genome decreased traces of whole genome duplication (WGD) to a 
minimum and led to the complete loss of some metabolic pathways (Dujon et al., 2004). 
Nevertheless, expansion of other genes gave C. glabrata other evolutionary advantages (Roetzer et 
al., 2011). Namely, expansion of genes involved in cell wall organization occurred in C. glabrata, 
possibly facilitating adherence to a broad spectrum of surfaces. It is important to emphasize that 
the gain and loss of these relevant genes might be crucial for functional differentiation between 
species and could be related to C. glabrata ’s adaptation as a mammalian commensal (Butler et 
al., 2004; Hittinger et al., 2004; Roetzer et al., 2011). Thus, robust adherence, resistance to 
antifungal drugs and to stress agents, and enhanced ability to sustain prolonged starvation render 
C. glabrata superior to S. cerevisiae in causing disease.  C. glabrata is also able to survive inside 
phagocytic cells for large periods of time which might support the establishment of disseminated 
infection and thus directly relate to its success not only as a commensal but also as a pathogen 
(Roetzer et al., 2011; Rodrigues et al., 2014). 
During a study of candidiasis in Portugal, it was discovered that one of the clinical isolates initially 
identified as C. glabrata, and phenotypically similar to this species, showed some different 
genotypic characteristics. After sequencing of the ITS regions and the D1/D2 region of ribosomal 
DNA genes, it was found that the degree of divergence was considerably high, which led to the 
description of a new species which was named Candida bracarensis. The type strain, 153 MT (CBS 
10154T), was isolated from a case of vaginal candidiasis in a medical institution of Braga, Portugal 
(Correia et al., 2006). The number of C. bracarensis isolates described is still low. Following the 
publication of the first two isolates as a cause of vulvovaginal candidiasis (VVC) in Portugal and 
from a blood culture in the United Kingdom in 2006 (Correia et al., 2006), only fourteen more 
have been reported. One isolate was identified in The John Hopkins Clinical Mycology Laboratory 
(Maryland) collection (Page et al., 2006), three were isolated from the throat and stool of two 
oncology patients and from a pelvic abscess in Baltimore (Bishop et al., 2008), two isolates have 
been recovered from a study of C. glabrata bloodstream isolates in San Francisco (Lockhart et al., 
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2009), and two bloodstream strains were isolated from a bone marrow transplant patient, all from 
the United States (Warren et al., 2010). Three more isolates were found in a Spanish collection of 
yeasts (Cuenca-Estrella et al., 2011) and one isolate was collected in a VVC patient in China (Li et 
al., 2014). Besides these published isolates, one C. bracarensis isolate was identified by Center 
Hospitalier J. MIJOZ - Laboratoire de Bacteriologie, and another by our group among Candida sp. 
isolates from Instituto Nacional de Saúde Ricardo Jorge, Lisbon, Portugal.  
C. bracarensis belongs to the glabrata group (Figure 1) which, apart from C. glabrata, includes two 
other species usually isolated from human infections (C. bracarensis and C. nivariensis) and one 
from the environment (Nakaseomyces delphensis, formerly Kluyveromyces delphensis) (Gabaldón 
et al., 2013). Although some studies have shown that the emerging pathogen C. bracarensis is 
more closely related to the non-pathogenic N. delphensis than to the most frequently isolated 
pathogen C. glabrata, (Correia et al., 2006; Gabaldón et al., 2013), the similarities shared by C. 
glabrata and C. bracarensis may represent adaptations that may have facilitated, even if not 
directly triggered, the emergence of pathogenicity towards humans (Gabaldón et al., 2013. In all 
infections attributed to C. bracarensis every isolate was initially identified as C. glabrata based on 
the routinely used phenotypic tests (Correia et al., 2006; Bishop et al., 2008; Lockhart et al., 
2009; Warren et al., 2010; Cuenca-Estrella et al,. 2011; Li et al,. 2014). This highlights the high 
grade of phenotypic similarities shared by C. bracarensis and C. glabrata and emphasizes the 
problem of misidentification between these closely related Candida species (Romeo et al., 2009). 
Thus, the true incidence of this organism in cases of candidiasis is yet to be determined (Warren et 
al., 2010). 
Similar to other Candida species, C. bracarensis has been recovered from multiple body sites, 
especially from mucosal surfaces, and is clearly associated with colonization and infection (Correia 
et al., 2006; Bishop et al., 2008; Lockhart et al., 2009). So far, little is known about this species 
regarding its prevalence, susceptibility patterns, and clinical significance. However, physiological 
and biochemical tests demonstrate a great similarity between C. glabrata and C. bracarensis. 
Indeed, C. bracarensis and C. glabrata are morphologically indistinguishable except for the color 
change on CHROMagar and lysine assimilation (Warren et al., 2010). C. bracarensis can be 
presumptively identified based on the production of white colonies on CHROMagar agar, 
microscopic features like small budding yeast cells without hyphae or pseudohyphae, and a rapid 
trehalose test. Identification can be further confirmed by DNA sequence analysis targeting the ITS 
and/or D1/D2 regions (Correia et al., 2006; Warren et al., 2010; Esposto et al., 2013).  
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Relatively to antifungal resistance, Warren and co-workers (2010) have shown that two of the eight 
C. bracarensis isolates tested for antifungal drug susceptibility were drug resistant, being one 
resistant to amphotericin B and another resistant to all the azoles. It was also reported that C. 
bracarensis were able to form biofilms composed by proteins and carbohydrates, had hemolytic 
activity, one isolate had extracellular proteinase activity, and were unable to produce phospholipase 
and filamentous forms (Moreira et al., 2015).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Phylogenetic tree of 22 Saccharomycotina species. The tree was constructed from 
maximum likelihood analysis based on concatenated alignment of one-to-one orthologs of 603 widespread 
genes. Species names in red and with an asterisk indicate human fungal pathogens. Underlined species 
names correspond to the newly sequenced species. Important evolutionary events such as the Whole 
Genome Duplication (WGD) or the genetic code transition in the Candida clade (CTG) are marked on the 
tree (Gabaldón et al., 2013).  
 
3. Candida  virulence factors !
Candida pathogenicity is a complex and higly regulated multifactorial process (Brown et al., 2007). 
Several studies suggest that C. glabrata has few virulence tributes taking into account its relatively 
less exuberant pathogenic nature (De Bernardis et al., 1996; Fidel et al., 1996). However, the high 
mortality rate due to C. glabrata infections and the rapidity of the spread of disease would argue to 
the contrary (Fidel et al., 1999). C. glabrata pathogenicity depends not only on its characteristics 
but also on the host physiology conditions, specifically, on the state of the host immune system 
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(Rodrigues et al., 2014). C. glabrata shares some virulence factors with C. albicans including 
phenotypic switching, biofilm formation and the ability to adhere to host tissues. Despite the lack of 
several virulence mechanisms characteristic of C. albicans, such as hypha formation and 
extracellular proteolytic activity, C. glabrata is capable of establishing successful disseminated 
infections (Rai et al., 2012). If C. glabrata virulence is low, the lack of hyphae formation may be a 
contributing factor. Indeed, hypha formation is a recognized attribute of increased adherence and 
tissue invasion of C. albicans, as well as a means of increasing proteolytic enzyme elaboration and 
antigen modulation (Brunke and Hube, 2013). Secreted aspartyl proteinase production by C. 
albicans has been frequently associated with pathogenicity (Naglik al., 2003), however, the 
contribute of these hydrolytic enzymes to C. albicans pathogenicity seems to highly depend on the 
type of infection (Lermann and Morschhäuser, 2008; Correia et al., 2010). In general, little is know 
about proteinase production by C. glabrata, but in the few studies available, C. glabrata was 
described as not presenting extracellular proteinase activity (Kaur et al., 2005). Nevertheless, in a 
recent study C. glabrata was demonstrated to up-regulate members of the C. glabrata YPS gene 
family encoding putative GPI-linked aspartyl proteases upon contact with macrophages (Kaur et al., 
2007). The main role of Yps proteases is to remodel the cell surface by removal of certain GPI-
CWPs in response to different host environments (Kaur et al., 2007; Bairwa et al., 2014; 
Supúlveda-González et al., 2015). 
Another virulence factor of C. albicans is phenotypic instability, termed “phenotypic switching”, 
which allows isolates to switch colony phenotype without affecting the identifiable genotype (Yang, 
2003). This feature, that contributes to the morphological and phenotypic plasticity of C. albicans, 
is implicated in the control of the sexual cycle and in virulence. Regulation of other virulence-
associated traits (e.g. hyphal formation and secretion of proteinases) is affected by this virulence 
attribute (Kaur et al., 2005). Phenotypic switching was also reported in C. glabrata (Csank and 
Haynes, 2000; Lachke et al., 2002). Intriguingly, in some patients infected with a single C. glabrata 
strain, dramatic differences were seen in the proportions of switch phenotypes at oral and vaginal 
locations, which suggest the potential selection of particular switch phenotypes at different 
anatomical sites (Brockert et al., 2003). The ability to switch would allow rapid adaptation of the 
organism to different stressful environments, and is a proposed route for the generation of 
phenotypic diversity species (Kaur et al., 2005). 
Adherence is considered essential in the establishment of disease and contributes to the 
persistence of the organism within the host. Adherence of Candida species to host epithelial tissue 
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is thought to play an important role in the virulence of these organisms. Also, pathogenic yeasts 
exploit their ability to adhere to abiotic surfaces, such as plastic prostheses and catheters, to gain 
access to the bloodstream and internal organs of the patients (Kojic and Darouiche, 2004). In C. 
albicans adherence is mediated by numerous defined adhesins including those encoded by HWP1, 
expressed only on hyphae, and by members of the ALS (agglutinin-like sequence) gene family 
(Sundstrom, 1999; Sheppard et al., 2004). The Als3 protein, in particular, seems to play a vital 
role in adhesion, since its deletion strongly reduces adherence to epithelial cells (Brunke and 
Hube, 2013). In C. glabrata, adherence is mediated largely by the EPA family of genes, which, like 
HWP1 or ALS genes encode GPI-anchored cell wall proteins (Cormack et al., 1999). These 
adhesins of C. glabrata are related to the Flo proteins of S. cerevisiae, which are responsible for 
flocculation during the brewing process (Brunke and Hube, 2013). C. glabrata possesses a family 
of at least 23 EPA genes, which encode cell surface proteins capable of mediating adherence to 
epithelial cells and macrophages (Mundy and Cormack, 2009; Halliwell et al., 2012; Brunke and 
Hube, 2013). Gabaldón and co-workers (2013) identified 12 chromosomes and 12 members of 
the EPA family in C. bracarensis. It has been postulated that the EPA genes could be differentially 
regulated in order to maximize adherence to different host cell types during infection (Halliwell et 
al., 2012). 
 
4. Candida cell wall 
 
Different virulence factors are involved in Candida pathogenicity, but the role of the cell wall in the 
pathogenesis of the fungus cannot be undervalued. The cell wall is the dynamic and complex 
structure that first comes into contact with host cells and carries basic antigenic determinants of 
the fungus. Equally important is the contribution of the cell wall for the adherence of the pathogen 
and establishment of a connection with the host, which depends on the chemical composition and 
linkages of the cell wall polysaccharides (Ruiz-Herrera et al., 2006; Hall and Gow, 2013; Hall, 
2015).   
The Candida cell wall is a coherent structure, made by ordered arrangement of its different 
components that provides the fungus protection against physical, chemical and biological 
aggression, and is responsible for its morphology (Ruiz-Herrera et al., 2006; Hall and Gow, 2013; 
Alvarez, 2014). The general Candida cell wall is composed by 90% carbohydrate and 10% protein. 
As a generalization, carbohydrates dominate the immune recognition and proteins have a key role 
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in adhesive interactions with host cell surfaces (Gow and Hube, 2012). The three major forms of 
polysaccharides in Candida species are mannans, glycoprotein containing mannose in a variety of 
α and β linkage arrangements; β-glucans, which comprise mainly β-1,3-glucan and β-1,6-glucan; 
and chitin (poly-β-(1,4)-N-acetylglucosamine-GlcNAc) or its deacetylated form, chitosan (Galán-Díez 
et al., 2010; Gow and Hube 2012). The cell wall inner layer is comprised of chitin and glucans that 
act as the cell’s skeleton, and both of these molecules convey strength and shape to the cell wall. 
By contrast, the mannans and proteins of the outer cell wall layer are less structured, but have low 
permeability and porosity that are essential for cell adhesion, biofilm formation and ultimately to 
Candida virulence (Hall, 2015). These proteins are decorated with simple linear O-linked glycans 
and complex branched N-linked mannans. As these mannans are located on the periphery of the 
cell wall, they play key roles in innate immune recognition (Hall, 2015). Therefore, the mannan 
layer affects the resistance of the wall to attack by molecules of the host defence and the 
permeability of the wall to antifungal drugs, but does not influence cell shape (Gow and Hube, 
2012). A representative scheme of C. albicans cell wall is shown in Figure 2. Global transcriptional 
and proteomic studies investigating the effects of environmental parameters identified that many of 
the cell wall proteins are differentially expressed in different environments (Bruno et al., 2010).  
Growth in different environments also affects the carbohydrate content of the cell wall (Ene et al., 
2012).  The presence or absence of specific proteins within the cell wall and the exposure of 
specific carbohydrates will affect cell wall structure and composition, ultimately affecting innate 
immune recognition (Ene et al., 2012; Hall, 2015).   
At the moment, no evidences of the presence of α-glucans in the Candida genus have been 
reported. (Ruiz-Herrera et al., 2006) Candida cell wall only comprises β-glucans, and these are the 
most abundant polysaccharides of the fungal cell wall in general. They are polymers of glucose 
joined by β-1,3-glycosidic or β-1,6-glycosidic linkages. Candida cell wall contains both β-1,3 and β-
1,6-glucans, but no mixed intrachain β-1,3/1,6 linkages (Ruiz-Herrera et al. 2006; Hall, 2015). In 
yeats the cell wall proteins are bound to the β-glucan/chitin inner layer through the lateral chains 
of β-1,6-glucan or, to a lesser extent, to β-1,3- glucan (Ruiz-Herrera et al., 2006). 
β-glucans have been reported to modulate inflammatory responses in vitro and in vivo (Nakagawa 
et al. 2003). The immunomodulatory effects of β-glucans are influenced by their degree of 
branching and their tertiary structure, and different types of glucans have different biological effects 
(Bain et al., 2014; Bonfim-Mendonça et al. 2014).  
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The synthesis of β-glucans is a complex reaction involving several enzymes located at different cell 
compartments. Because of that, glucan synthases constitute the target of important inhibitors of 
glucan synthesis, and therefore of wall growth (Ruiz-Herrera et al., 2006). To inhibit fungal growth, 
various efficacious antibiotics have been developed to interfere with cell wall synthesis by targeting 
β-1,3-glucan synthase (Selvakumar et al., 2006).  However, no antifungal antibody that could 
inhibit β-1,3-glucan synthase activity has ever been reported. Glucose synthase is composed by 
two related catalytic subunits, Fks1p and Fks2p, and a regulatory sub-unit, Rho1p small GTPase 
(Inoue et al., 1995; Drognova et al., 1996; Qadota et al., 1996). All components of the glucose 
synthase are localized on the plasma membrane at the site of cell wall remodelling (Utsugi et al., 
2002).  
Figure 2:  The structure of the Candida albicans cell wall (adapted from Brown et al., 2014). The 
three major forms of polysaccharides in Candida species are: (a) mannans, (b) β-glucans, which comprise 
mainly β-1,3-glucan and β-1,6-glucan, and (c) chitin . 
 
Chitin is a linear polysaccharide made of several units of N-acetylglucosamine. Due to this 
crystalline arrangement, chitin is one of the most insoluble natural products, and this explains why 
its linkages to β-1,3-glucan form the basic cell wall scaffold to which mannoproteins are covalently 
associated (Ruiz-Herrera et al. 2006, Levitz, 2010). Although chitin only comprises a small amount 
of the fungal cell wall (3% dry weight), subtle changes in its concentration can have a large impact 
on fungal biology. An increase in chitin content from 3% to 10% greatly impacts on antifungal 
sensitivity and recognition by the innate immune system (Mora-Montes et al,. 2011). 
Treatment of Candida with caspofungin, an echinocandin that inhibit the synthesis of β-(1,3)-
glucan, has been reported to cause a compensatory increase in chitin content (Walker et al., 
2013). This activation of chitin synthesis was observed in isolates of C. albicans, in response to 
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caspofungin treatment, however, C. glabrata isolates demonstrated no exposure-induced changes 
in chitin content (Walker et al., 2013). Remarkably, the chitin response is fully reversible upon 
removal of cell wall stress, complicating the evaluation of the precise significance of this 
phenomenon in vivo.  
 
5. Interaction between Candida spp. and host immune cells !
The host immune response to fungal infections comprises diverse mechanisms and involves both 
innate and adaptive immunity. At the same time that the immune system is eliminating pathogens 
and toxic substances, it must avoid responses that produce excessive damage of self-tissues or 
even that might eliminate beneficial commensal microorganisms (Chaplin et al., 2010). The 
immune system uses a complex array of protective mechanisms that rely on detecting structural 
features of the pathogens that mark them as distinct from host cells, to control and usually 
eliminate these organisms and toxins. Such host-pathogen discrimination is essential to permit the 
host to eliminate the threat without damaging its own tissues (Romani, 2011). 
 
5.1 Overall of Immune System: organization and role !
The immune system is a collection of barriers, cells and soluble factors that interact and 
communicate with each other in an extraordinary complex way (Murphy et al., 2007). Any 
discussion about the immune response usually begins with the physiologic and anatomic barriers 
that prevent pathogens from entering the body, destroy them after they enter, or flush them out 
before they can establish themselves. They are part of the body’s most basic defence mechanisms 
and are associated with constitutive mechanisms of innate defence (Sajjad et al. 2010; Romani, 
2011). These barriers include skin, mucosal epithelial cells of respiratory, gastrointestinal and 
genitourinary tracts, and are in constant interaction with pathogens (Romani, 2011). The anatomic 
barrier defences provide the crucial primary line of defence against pathogens and are 
continuously working to protect against a broad range of pathogens, although they are not, by 
themselves, a response to infections (Turvey and Broide, 2010). Whenever that first line of defence 
is breached, the host innate immune system plays a crucial role in the early recognition of invading 
pathogens which will subsequently trigger a proinflammatory response that will attack the invading 
substances  (Traynor and Huffnagle, 2001).    
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Despite a certain lack of specificity, innate immunity effectively distinguishes self from non-self and 
activates adaptive immune mechanisms by the provision of specific signals (Medzhitov and 
Janeway, 1997; Romani, 2004). The innate immune system confers rapid recognition of microbial 
infections through a limited repertoire of germ line-encoded receptors that recognize a group of 
conserved molecular patterns (pathogen-associated molecular patterns, PAMPS) common to broad 
groups of microbial agents (Janeway and Medzhitov, 2002; Roeder et al., 2004; Romani, 2004; 
Netea, et al. 2015). The innate immune response is mediated mainly by phagocytic cells such as 
granulocytes, macrophages, and dendritic cells (DC) (Aderem, 2003; Mogensen, 2009). However, 
other factors such as cytokines and chemokines, the complement system, and also natural killer 
cells, play an important role in innate immunity (Mogensen, 2009). Some participants of the innate 
immunity, such as dendritic cells and the complement system, may assist the induction of adaptive 
immunity (Dunkelberger and Song, 2010; Steinman and Hemmi, 2006). The adaptive immune 
system is responsible for the elimination of pathogens in a later phase of infection and is involved 
in the generation of immunological memory, a unique feature of the adaptive immune system 
(Murphy et al. 2007). The hallmarks of adaptive immunity are its ability to learn, adapt and 
remember (Alberts et al. 2002). 
There are two broad classes of adaptive responses, antibody responses and cell-mediated immune 
responses, which are carried out by B and T lymphocytes, respectively. In antibody responses, B 
cells are activated to secrete antibodies. The antibodies circulate in the bloodstream and permeate 
the other body fluids, where they bind specifically to the antigen that stimulated their production. 
Binding of antibodies to their specific antigens may inactivate pathogens by blocking their ability to 
bind to receptors on host cells. Antibody binding also marks invading pathogens for destruction, 
mainly by making it easier for phagocytic cells of the innate immune system to ingest them (Alberts 
et al. 2002; Bonilla and Oettgen, 2010). Summing up, to protect the individual effectively against 
disease, the immune system must fulfil four main tasks. The first is the immunological recognition, 
where the presence of invading pathogens and establishment of infection must be detected. The 
second task is the control of the infection and, if possible, the complete elimination of the pathogen 
which brings into play immune effector functions. Immune regulation, or the ability of the immune 
system to self-regulate, is thus an important feature of immune responses and would constitute the 
third task. The fourth task is to protect the individual against recurrent disease due to the same 
pathogen and is related to the immunological memory.  
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5.2 Pathogen recognition strategies and innate sensing  !
The immune system does not remain ignorant of commensal or ubiquitous fungi, and thus, a fine 
balance between pro and anti-inflammatory signals is required to maintain a stable host–fungus 
relationship, the disruption of which can have pathological consequences (Romani, 2011). 
The first step in triggering an immune response to fungi is the recognition of invading fungal 
pathogens via pattern recognition receptors (PRRs), which are located mainly in host cells of the 
innate immune system (Netea and Marodi, 2010). All types of PRRs i) recognize PAMPs, that are 
vital for the survival of the microorganism; ii) are expressed constitutively in the host and detect the 
pathogens regardless of their life-cycle stage; iii) are germline encoded, nonclonal, expressed on all 
cells of a given type, and independent of immunologic memory (Netea and Marodi, 2010; Romani 
2011). Overall, in response to fungal recognition, PRRs on phagocytes initiate downstream 
intracellular events that promote the activation of the immune system and the clearance of fungi, 
with the specific immune response generated depending on the cell type involved (Akira et al. 
2006; Romani, 2011). The recognition of PAMPs is done by several series of PRRs, such as Toll-
like receptors (TLRs), C-type lectin receptors (CLRs), Nucleotide-binding oligomerization domain 
(NOD)-like receptors (NLRs) and the galectin family receptors (Taylor et al., 2007; van der Meer et 
al., 2010; Mora-Montes et al., 2011; Romani, 2011; Netea et al. 2015), as represented in Figure 
3.  
 
Figure 3: Signalling pathways in innate recognition of fungi. PAMPs and damage-associated 
molecular patterns (DAMPs) that are present during fungal infections are recognized by PRRs. Together, 
these signalling pathways induce the secretion of cytokines and chemokines and initiate phagocytosis to 
clear Candida infections (Adapted from Netea 2015).!
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5.2.1 Fungal sensing by TLRs !
TLRs are cell-membrane-associated (TLR1, TLR2, TLR4, TLR5 and TLR6) or intracellular (TLR3, 
TLR7, TLR8 and TLR9) receptors that have been implicated in the recognition of fungal 
components. Is difficult to precise which is the exact molecular nature of fungal PAMPs that 
activate specific TLRs, due to the often collaborative mechanism of TLR recognition and the 
plasticity of the fungal cell wall. Membrane-bound TLRs, such as TLR2, TLR4 and TLR6, are 
thought to mainly recognize mannoprotein constituents of the fungal cell wall: TLR2 recognizes 
phospholipomannan, TLR4 recognizes O-linked mannans, and TLR6 is involved in the recognition 
of zymosan, which is comprised of β-1,3-glucan and mannans and TLR9 detects fungal DNA 
(Romani, 2011; Netea et al. 2015). It has also become apparent that the intracellular receptors 
that recognize cytoplasmic nucleic acids, namely TLR3 and TLR9, may also have a role in anti-
Candida host defence (Netea et al., 2015). Whereas fungal PAMPs are recognized by a number of 
TLRs these might not the primary receptors driving pathogen engulfment (Bourgeois and Kuchler, 
2012).  !
5.2.2 Fungal recognition by CLRs  !
CLRs are the most important family of innate receptors in the recognition of Candida species. CLRs 
are mainly membrane-bound receptors that recognize polysaccharide structures of the Candida cell 
wall. Dectin-1 recognizes β-1,3-glucans, whereas the macrophage mannose receptor (MR) and DC-
SIGN senses N-linked mannans (Netea et al. 2008; Romani, 2011; Netea et al. 2015), and Dectin-
2 usually recognizes α-mannans. Several studies demonstrated that mice with deficiencies in 
CLRs, namely Dectin-1, Dectin-2, and MINCLE, or CARD9 are more susceptible than wild-type mice 
to disseminated invasive candidiasis, which is associated with reduced T helper Th17 cell 
frequency (Bishu et al., 2014). 
 
Recognition of β-glucan 
Different authors suggest that β-glucans are shielded from immune recognition by the 
mannoproteins in C. albicans and that unmasking these polysaccharides results in the induction of 
proinflammatory responses (Davies et al., 2004; Netea et al., 2015). The most well-studied β-
glucan receptor is Dectin-1 (also known as CLEC7A), expressed mainly on monocytes and 
macrophages, but also in dendritic cells and neutrophils (Brown et al., 2002; Brown and Gordon, 
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2001). Recognition of β-glucans by Dectin-1 can trigger phagocytosis of fungal pathogens and 
protective inflammatory responses (Brown, 2006). Activation of this receptor has been shown to be 
immunostimulatory, stimulating reactive oxygen species (ROS) production in murine cells 
(Wellington et al. 2009). Dectin-1 signals via a novel hemITAM motif that becomes phosphorylated 
by Src family kinases on receptor engagement, as well as through the RAF1 kinase signalling 
pathway. This allows recruitment and activation of the spleen tyrosine kinase (Syk), which then 
couples to downstream pathways, including those leading to production of ROS and, via the 
adaptor CARD9, to the activation of NF-kB. The latter, together with transcription factors activated 
by MAP kinases downstream of Syk, regulates the expression of innate response genes, including 
those encoding co-stimulatory molecules and proinflammatory cytokines and chemokines (Brown 
et al., 2002; Hernanz-Falcón et al., 2009; Netea et al., 2015).  
In addition to inducing direct cellular activation, engagement of Dectin-1 intensifies responses to 
TLR2 and TLR4 ligation, TLRs that recognize mannan-containing structures (Netea et al., 2015)  
 
Recognition of mannans  
Both mannans and mannoproteins from the C. albicans cell wall have important 
immunostimulatory activities, ranging from stimulation of cytokine production to induction of DC 
maturation and T-cell mediated immunity. Mannoproteins induce mainly Th1 type cytokine profiles, 
which have protective effects against disseminated C. albicans infections (Netea et al., 2008). 
Mannans and mannoproteins are recognized by several CLRs, including the mannose receptor, 
Dectin-2 (CLEC6A), dendritic cell-specific ICAM3-grabbing non-integrin (DC-SIGN; also known as 
CD209) and MINCLE (also known as CLEC4E) (Netea et al., 2008; Netea and Marodi, 2010; Netea 
et al., 2015). The mannose receptor is primarily expressed on macrophages and recognizes N-
mannan (Netea et al., 2008). Dectin 2, which is mainly expressed on dendritic cells, macrophages 
and neutrophils and generally recognizes α-mannan. In addition to its role in modulating Th17-type 
cell responses, Dectin-2 has been associated with the production of ROS and with phagocytosis 
and elimination of C. glabrata (Netea et al., 2008; Netea et al., 2015). Dectin-2 has been reported 
to form heterodimers with Dectin-3, and owing to its short intracytoplasmic tail, Dectin-2 must 
interact with the FcγR to induce intracellular signals. Dectin-2 is encoded by a different gene cluster 
to the β-glucan receptor Dectin-1 and does not recognize β-glucans (Ifrim et al., 2014; Netea et al., 
2015).  
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Mincle is a CLR mainly expressed on macrophages/monocytes, myeloid dendritic cells, and 
neutrophils. It recognizes carbohydrate structures containing α-mannans and is responsible for 
inducing protective responses, largely by stimulating TNF-α production (Netea el at., 2015). Like 
Dectin-2, MINCLE signalizes after dimerisation with the FcγR adaptor protein (Naglik, 2014).   
DC-SIGN is present especially on DCs but also on macrophages and recognizes Candida N-linked 
mannan. Its activation promotes adaptive immune responses by inducing the expression of 
cytokines that drive the activation of Th cells (Netea et al., 2008; Netea et al., 2015). !!
5.2.3 Fungal recognition by NLRs  !
NLRs are cytoplasmic receptors that achieve several important biological functions, including the 
recognition of bacterial peptidoglycans, antigen processing and presentation, activation of the 
inflammasome, and are also implicated in sensing fungi. NOD1 and NOD2 are two well-
characterized NLRs that are involved in the recognition of gram negative and gram positive bacteria 
components and both NOD1 and NOD2 have been shown to be important for the response to 
Aspergillus fumigatus keratitis (Zhang et al., 2014; Wu et al., 2015). The role of these NLRs to 
Candida infection is not clear, since some authors stated that these receptors were not associated 
with Candida recognition (Van der Graaf et al., 2006), while others reported recognition and 
involvement of chitin-mediated responses, especially the production of IL-10 in the context of 
interaction between NOD2, MR and TLR9 (Wagener et al., 2014). 
Other NLRs such as Nlrp1, Nlrp3 and Nlrp4 oligomerize to form inflammasome complexes. 
Inflammasome oligomerization leads to the cleavage and activation of Caspase-1, which promotes 
the processing and secretion of the proinflammatory cytokines IL-1β and IL-18 (Netea et al. 2008; 
Netea and Marodi, 2010; Romani, 2011). Several NRL have been associated with a protective 
response to fungi (Veerdonk et al., 2015). Both S. cerevisiae and C. albicans are able to trigger 
Nrlp3 activation leading to IL-1β production and the induction of Th1 and Th17 cell differentiation 
(Kumar et al., 2009). While NLRP3 activation is critical for the control of both systemic and 
mucosal C. albicans infections Nrlc4 is important in limiting mucosal candidiasis (Tomalka et al., 
2011). Nrlp10 signalling affected mostly the adaptive response to C. albicans (Joly et al., 2012).  
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5.2.4 Fungal sensing by other PRRs !
Complement receptor 3 (CR3) is a widely expressed β2-integrin that recognizes several 
endogenous and exogenous ligands, pathogens that have been opsonized by iC3b (the inactivated 
form of complement component C3b) and carbohydrates, including β-glucans. This receptor has 
two binding sites, one for iC3b and a different one for β-glucans, and is mainly involved in the 
recognition of β-glucans by neutrophils and macrophages. Recognition by CR3 induces 
phagocytosis but does not trigger protective host responses, such as the respiratory burst, and can 
repress proinflammatory signals (Netea et al., 2008; Netea et al., 2015).  
Galectin-3 is one of more than 15 members of the β-galactoside-binding lectin superfamily involved 
in the recognition of β-1,2-mannosides β–mannosides (Chen et al., 2015). Murine macrophages 
can bind, and directly kill, C. albicans that harbour β-1,2-mannosides, but not S. cerevisiae, which 
lack those residues, through galectin-3. In response to β-1,2-mannoside-binding, galectin-3 induces 
a protective antifungal response in mouse macrophages through secretion of TNF-α  in 
collaboration with TLR2 (Jouault et al. 2006; Kohatsu et al., 2006; Gazendam et al., 2014).  
The scavenger receptors are defined as a family of molecules that share the ability to bind 
polyanionic ligands of both pathogen and self origin. CD36 and SCARF1 have also been reported to 
recognize β-glucans of Candida species cell wall and to have a role in the protective response to 
fungi (Means et al., 2009; Means, 2010).  
 
 
6. Candida invasion and host cell associated mechanisms of defence  !
After the initial recognition of fungal PAMPs by the various families of PRRs, a chain of effector 
mechanisms is initiated that ultimately leads to the clearance of the invading fungal pathogen. One 
of the key steps in Candida pathogenesis is adherence, followed by invasion, usually into epithelial 
cell layers that also display a role in controlling the commensal state of Candida by producing β-
defensins, which have potent antifungal activity (Netea et al., 2015). C. albicans, can invade host 
cells via two mechanisms: induced endocytosis by host cells and active penetration by C. albicans 
hyphae (Wächtler et al., 2011; Wächtler et al., 2012). Induced endocytosis seems to be important 
at the early stages of invasion (Phan et al., 2007; Wächtler et al., 2011; Zhu et al., 2012). In C. 
albicans, active penetration of host cells by hyphae result of a combination of physical forces 
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exerted by the extending filaments, the secretion of hydrolytic enzymes and yet unknown damaging 
factors, which finally leads to disruption of the host cell membranes (Wächtler et al., 2012). 
Secreted aspartyl proteinases (Sap) are the most well studied hydrolytic enzymes produced by C. 
albicans during infection and are required for full virulence in models of mucosal and disseminated 
infection (Schaller et al., 2002; Naglik et al., 2003; Schaller et al., 2004; Moyes et al., 2010). 
Conversely, C. glabrata does not form hyphae nor produce Saps, but still can invade and be found 
within host tissues.  A possible route to breach natural barriers would be via trauma, catheters, 
surgery or parenteral nutrition (Perlroth et al., 2007). However, even in the absence of such 
breaches, C. glabrata invades into deeper tissues and readily disseminates in a chicken embryo 
model of fungal infection, and superficially invades the mucosal compartment in a 3-D model of 
oral mucosa (Li et al., 2007; Jacobsen et al., 2011). The strategy of invasion remains unclear 
although S. cerevisiae is known to form agar-invasive pseudohyphae under in vitro starvation 
conditions, and one report even described psedohyphae formation by C. glabrata in vitro (Gimeno 
et al., 1992; Csank and Haynes, 2000). However, in vivo, Candida entry may rely on endocytosis 
instead of active penetration, with close to no host cell damage. Probably because of low host 
tissue damage, the cytokine profile of epithelia infected with C. glabrata differs dramatically from 
that of C. albicans-infected cells (Schaller et al., 2002; Li et al., 2007; Jacobsen et al., 2011).  
Once Candida has penetrated the host tissues it will first encounter the tissue resident 
macrophages (Netea et al., 2015), key effector cells in antifungal defence. These are phagocytic 
immune cells, derived from monocyte differentiation, that are involved in the first line of defence 
during microbial invasion, produce inflammatory cytokines and chemokines that recruit and 
activate other immune cells at the site of infection (Netea et al., 2015). Macrophages express a 
wide range of different opsonic and non-opsonic receptors able to detect non-self particles. Opsonic 
receptors, such as the Fc receptor or complement receptor families are able to recognize particles 
coated (opsonized) with antibody or complement proteins (Johnston and May, 2013). In contrast, 
non-opsonic receptors are PRRs that directly sense the surface of microorganisms (Gilbert et al., 
2014).  
Upon pathogen engulfment, the macrophage must then digest it, now confined into a phagosome 
(digesting vesicle). To complete the digestion, the phagosome must mature via the fusion of early 
and late stage endosomes and ultimately fuse with the lysosomes, generating a full destructive 
phagolysosome (Kinchen and Ravichandran, 2008; Seider et al., 2011). Acidification of the 
phagosome occurs in two distinct stages. First a primary acidification that results in a relatively 
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small drop in pH, and subsequently V-type (vacuolar) ATPase proton pumps driven by hydrolysis of 
ATP are trafficked to the phagosome at late stages. Once the pH is suitably reduced, acid-
dependent proteases, such as cathepsin D, are activated to degrade the pathogen (Kinchen and 
Ravichandran 2008). Furthermore, during phagosome biogenesis a battery of ROS such as 
peroxide, superoxide anions and hydroxyl radicals, reactive nitrogen species, and antimicrobial 
peptides are transported into the organelle (Segal et al., 2005; Seider et al., 2011; Mayer et al. 
2013). Several studies suggest that live Candida (C. albicans and also C. glabrata) suppresses the 
production of ROS by phagocytes. Suppression of ROS production does not occur with S. 
cerevisiae, suggesting that it may be an important factor in the pathogenesis of Candida infection. 
Suppression of ROS production appears to override stimulatory signals from the cell wall, including 
those induced by β-1,3-glucan (Wellington et al., 2009; Seider et al., 2011).  
C. albicans and C. glabrata interfere with macrophage phagosome maturation to avoid acidification 
and limit the hydrolytic attack (Fernandez-Arenas et al., 2009; Seider et al., 2011). However, 
neither the mechanisms to limit phagosome maturation nor the relative contribution of these to 
fungal survival are known. It is known, nevertheless, that blocking phagosome–lysosome 
maturation plays an important role for many intracellular pathogens (Gilbert et al. 2014). 
In vitro experiments suggest that C. albicans can germinate within macrophages to causing 
macrophage membrane rupture, and eventually lysis, allowing C. albicans to escape. Intriguingly, 
this macrophage lysis may be a result of pyroptosis instead of physical membrane rupture 
(Calderone and Sturtevant 1994; Vazquez-Torres and Balish 1997; Wellington et al., 2012). 
Candida species that do not filament, such as C. glabrata, are not always less virulent, indicating 
that other mechanisms exist to allow survival, replication, and escape from macrophages after 
being phagocytosed.  Some authors defend that C. glabrata attracts and infect macrophages, and 
use them as “trojan horses”, to hide from immune surveillance and to spread to the organs, 
similarly to what is seen in Cryptococcus neoformans infections (Charlier et al., 2009; Brunke and 
Hube, 2013). Degradation and recycling of endogenous cellular components (autophagy) seem to 
be another intracellular survival strategy of C. glabrata within macrophages (Roetzer et al., 2010).  
Other cells shown to be essential for the host response against Candida species are DCs. DCs can 
also ingest and kill Candida cells, however, they are less efficient than macrophages at fungal 
killing. The ability of a given DC subset to respond differentially and to activate distinct intracellular 
signalling pathways following the ligation of different PRRs, confers unexpected plasticity to the DC 
to shaping T cell responses to infection and following vaccination. DCs are important for processing 
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and presenting fungal antigens for the activation of Th cell responses (Netea et al., 2015). Of the 
diverse T-cell subsets, Th1, Th17, and regulatory T cells (Treg) have been shown to be important in 
controlling C. albicans infection or pathology resulting from infection. Through the production of the 
cytokine IFN-γ Th1 cells are instrumental in the optimal activation of phagocytes at sites of 
infection (Blanco and Garcia, 2008, Romani, 2011), however, it is also clear that patients with 
genetic defects in the IL-12, IL-23 and IFN-γ pathways do not have increased susceptibility to 
mucosal candidiasis (Puel et al., 2012).   
Not only Th1, but also Th17 type responses are important for host defence against Candida 
species. In accordance, human Candida-specific Th cells were found to produce a combination of 
IL-17 and IFN-γ (Zielinski et al., 2012; Netea et al., 2015).  
Th17 cell activation occurs in fungal infections, mainly through the SYK–CARD9, signaling 
pathways in DCs and macrophages resulting in the production of cytokines that induce neutrophil 
recruitment and activation, and are responsible for the activation of epithelial cells and the release 
of antifungal β-defensins, often in a cooperative manner. The importance of Th17 immunity in 
response to C. albicans infections was first shown in murine studies of both systemic and mucosal 
candidiasis (Huang et al., 2004; LeibundGut-Landmann et al., 2007; Conti et al., 2009). However, 
human genetic deficiencies have indicated a role for the Dectin-1/CARD9, STAT3 and Th17 cell 
pathways in protection against mucosal infections but not against systemic candidiasis (Netea et 
al., 2015).  
It is now well established that a successful host immune response to C. albicans infection relies on 
the concerted and balanced action of Th1, Th17, and also Treg. Th1 and Th17 cells are 
undoubtedly important in host resistance to the different forms of candidiasis, however, their action 
must be counterbalanced in order to avoid harmful host inflammation. Studies in the murine model 
have shown that Treg are important in limiting the inflammatory immune response to C. albicans in 
systemic and mucosal candidiasis (De Luca et al., 2007; Netea et al., 2004), but their role might 
exceed a counterinflammatory function, since Treg might promote, rather than suppress, Th17 cell 
differentiation (Pandiyan et al., 2011). Indeed, in murine models of systemic candidiasis Treg 
depletion have shown to increase mice resistance to infection, while in a mucosal model of 
infection mice Treg depletion rendered mice more susceptible (Netea et al., 2004; Whibley et al., 
2014; Whibley and Gaffen, 2014), what could provide an explanation for why patients with Treg 
defects are prone to mucosal C. albicans infections.  
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In contrast to the reported protective Th1 and Th17-type immune responses that are important for 
a protective host response to Candida species (Carvalho et al., 2012), cytokines associated with 
Th2-type immunity have been shown to have contradicting roles. Adoptive transfer of IL-4, and also 
IL-10-deficient T cells in bone-marrow irradiated wild-type mice increased their resistance to 
systemic candidiasis (Mencacci et al., 2001). In accordance, IL-10-depleted mice showed greater 
resistance to candidiasis (Vazquez-Torres et al., 1999; Tavares et al., 2000), suggesting a negative 
role for these cytokines.  Conversely, early IL-10 administration was protective in IL-12 p40-
deficient mice and endogenous IL-4 was required for the development of protective Th1 responses 
to Candida albicans (Mencacci et al., 1998) 
 
7. Objectives and outline of the thesis !
Our research group described in 2006 a new fungal species, C. bracarensis, phenotypic and 
genetically related with C. glabrata and, to a lesser extent, with S. cerevisiae (Correia et al., 2006). 
The incidence of this new species has been increasing worldwide, being considered as an 
emerging pathogen. However, little is known about the characteristics of C. bracarensis as a 
pathogen and its interaction with the host.  
The main objectives of this work are: i) to evaluate C. bracarensis, C. glabrata, and S. cerevisiae 
resistance to several oxidative and cell wall stressors; ii) to analyze cell wall composition/structure 
of these yeats; iii) to characterize the interaction of C. bracarensis, C. glabrata, and  S. cerevisiae 
with cells of the host innate immune system, such as macrophages and dendritic cells;  
This dissertation is organized in four chapters:  
Chapter 1 consists of a general introduction. Chapter 2 contains the methodology used to carry 
out the experiments. Chapter 3 describes the main results obtained. Here, at first, a phenotypic 
characterization of several C. bracarensis, C. glabrata and S. cerevisiae strains is presented, 
concerning resistance to oxidative and cell wall stress agents and the composition/structure of 
yeasts cell wall. Then, data on the phagocytosis of yeasts by murine and human macrophages, as 
well as reactive oxygen species production by these phagocytes is shown. Finnally, the results on 
the interaction of yeasts with macrophages and dendritic cells and the elicited inflammatory 
response are presented. Chapter 4 consists of a general discussion of the experimental results 
and the main conclusions, and at last, future perspectives are also suggested. 
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1. Phenotypic and functional  characterization of C. bracarensis, C. glabrata 
and S. cerevisiae strains !
1.1 Fungal strains and yeast cell cultures !
 Five strains of each selected species (C. bracarensis, C. glabrata and S. cerevisiae) were analyzed, 
in a total of fifteen yeast strains, (Table 1). 
 
 Table 1: C. bracarensis, C. glabrata and S. cerevisiae strains used in this study  
 
All strains were maintained as frozen stocks in 30% glycerol at −80°C. Viable cells were obtained 
by cultivation on solid yeast extract-peptone-dextrose (YPD) medium (1% yeast extract, 2% peptone, 
2% glucose, 2% agar). Isolates were then grown in liquid YPD medium at 37°C and 140 rpm in a 
shaking incubator (3031-GFL, Germany) to late exponential growth (14-16 hours), recovered by 
!
Specie Strain Source Origin 
Candida 
bracarensis 
153MT/CBS10154T Vaginal swab Portugal 
246188 Vaginal swab Portugal 
445L Rectum France 
CL7030(L08/524) NS Spain 
NCYC 3133 Blood United Kingdom 
Candida 
 glabrata 
CBS 138 Faeces NS 
CIPO23 Respiratory fluid Portugal 
CIPO44 Faeces Portugal 
CIPO88 Vaginal swab Portugal 
Hemo1117 Blood Portugal 
Saccharomyces 
cerevisiae 
L557/ S288C Baker NS 
L559 Mucosa Portugal 
L560 Mucosa Portugal 
CIPO12 Faeces Portugal 
CIPO56 Respiratory fluid Portugal 
Candida 
albicans 
SC5314 /ATCC MYA-
2876 
NS United Kingdom 
   NS- not specified 
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centrifugation (10 minutes at 4500 g, 4°C) and washed twice in sterile PBS buffer. Cells were 
counted with a hemocytometer and brought to desired final concentration. 
Inocula were always confirmed by colony forming unit (CFU) counts on YPD solid medium for up to 
24 hours at 30/37°C. 
In selected experiments for cell wall characterization (Chapter 3), yeast cells were grown in liquid 
Sabouraud medium (2% peptone, 2% glucose) at 37°C and 140 rpm to late exponential growth (16 
hours). The use of Sabouraud instead of YPD medium had the aim of avoiding contamination of 
yeast cells by yeast extract, which could influence the results. Cells were recovered by 
centrifugation (20 minutes at 6400 g, 4ºC), washed three times with sterile distilled water, frozen, 
and freeze-dried (Christ Alpha 2-4, B. Braun, Germany). 
For preparation of heat-killed yeast cells, cells were grown as described before and incubated at 
70˚C for 30 minutes in sterile PBS.  
To fix yeast cells, these were incubated for 10 minutes in formol/ethanol (1:9) and washed three 
times with PBS for complete removal of formol/ethanol. 
1.2 Isolate identification by ITS-DNA sequencing 
The identity of all C. glabrata, C. bracarensis, and S. cerevisiae strains was confirmed by ITS-DNA 
sequencing, as follows:  
1.2.1 PCR amplification 
Colony-polymerase chain reaction (PCR) is a simple and fast methodology that uses directly the 
colony in the PCR tube to obtain the DNA template. To perform this technique, a protocol set at our 
laboratory was used (Vaz et al., 2011). In brief, a single colony was picked and transferred to a 
PCR microtube. For DNA release, the cells were lysed by thermal shock during 90 seconds in the 
microwave, and the microtubes were immediately placed on the ice to inhibit DNA degradation. 
Finally, a total volume of 24 µl of the PCR reaction mix was added. The specific primers ITS1 (5’-
TCCGTAGGTGAACCTGCGG-3’) and ITS4 (5’-TCCTCCGCTTATTGATATGC-3’) were used. The PCR 
reaction mix was performed by combining 1× PCR Buffer (20 mM TrisHCl [pH 8.4], 50 mM KCl), 
0.2mM of each of the four dNTPs, 2 mM MgCl2, 1 U of Taq polymerase and the 0.2 $M of each 
primer in a 10 µl final volume. The samples were amplified in a UNO II thermocycler (Biometra, 
Germany) and the PCR program consisted of an initial denaturation step of 6 min at 95°C, 
followed by 35 cycles of 20 s at 95°C, 20 s at 53°C, 1 min at 72°C, and a final extension step of 
5 min at 72°C. 
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DNA amplification was confirmed by electrophoresis, using an agarose gel 1.5% and Tris-acetate-
EDTA (TAE) buffer. The electrophoresis was performed at 100mV during 45 min. The gel was 
stained with Midori Green (LabGene, Suisse) for at least 30 min in agitation and visualized under 
UV-light on a UV transilluminator (Vilber Lourmat TF-20M, France). 
 
1.2.2 Purification of PCR products 
After amplification, a total of 35 µl of PCR product was used for DNA purification. 175µl of cold 
ethanol 95% and 70 µl of MgCl2 (2 mM) were added to the PCR product and the mix was mixed. 
The mixture obtained was incubated at -20°C by 20 min and centrifuged for 20 min at 14000 g, 
4°C. The supernatant was discarded and 250µl of 70% ethanol were added to the pellet. After a 
new centrifugation step the pellet was discarded. This step was performed twice. Finnaly, the pellet 
was dryed at room temperature (RT) and 25 µl of ultra pure water (pre-heated at 50-60°C) were 
added. 
 
1.2.3 Sequencing and data analysis 
After purification, the PCR products were sent to DNA sequencing by Eurofins (Portugal) 
(http://www.eurofins.pt), the electropherograms were analyzed through the CodonCode Aligner 
program, and the sequences were submitted to a BLAST search on NCBI’s database GenBank. 
 
1.3 SAP production  
Overnight yeast cultures were washed and plated (10 µl of cellular suspension OD640=0,5) on solid 
YCB-BSA (1,17% YCB; 0,01% yeast extract; 0,2% BSA, pH=5). Plates were incubated at 30ºC and 
37ºC during 10 days. After the incubation period, plates were stained with stain solution (25% 
methanol, 10% acetic acid, 0,1% amido black) for 15 minutes and were then washed several times 
with destain solution (25% methanol, 10% acetic acid). The determination of proteolytic activity was 
performed by observation of the presence or absence of an opaque inhibition halo around the 
colonies (Price et al., 1982). C. albicans was used as a positive control.  
1.4 Filamentation test 
Filamentation was induced by plating 10 µl of an overnight cellular suspension (OD640=0,5) on 
solid Spider medium (1% DIFCO Nutrient Broth; 1% Manitol; 0,2% dibasic potassium phosphate), 
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solid Slad medium (0,17% YNB; 2% dextrose; 50 !M  ammonium sulfate) or solid YPD 
supplemented with 10% fetal bovine serum (FBS, Invitrogene, USA). The plates were incubated at 
37ºC during 10 days. 
1.5 Susceptibility assay  
The sensitivity of the studied strains to various stress conditions was tested using overnight yeast 
cultures, washed and diluted to OD640= 0,5 in YPD fresh medium. Drop tests were performed by 
spotting 5 µl of the serially diluted cell suspensions onto YPD plates supplemented with following 
compounds: CongoRed (70 µl/ml and 250 µl/ml); caffeine (10 mM and 20 mM); caspofungin (75 
ng/ml, 120 ng/ml and 180 ng/ml); Calcofluor White (50 µg/ml and 250 µg/ml); SDS (0,02%, 
0,05% and 0,15%); NaCl (1M and 2M). to test the susceptibility to H2O2, the overnight grown 
cultures were incubated with 20 mM or 50 mM of H2O2 and were kept under the same growing 
conditions during 3 hours. Plates were incubated for 48 h at 30ºC and 37ºC before observation. 
 
2. Characterization of cell wall composition/structure of C. bracarensis, C. 
glabrata and S. cerevisiae  !
2.1 Extraction of yeast polysaccharides!
An aqueous suspension of yeast cells was submitted to 15 min of sonication, and the solubilized 
material was separated from the insoluble residue by centrifugation at 4°C and 5500 g during 20 
min.  
The yeast cells residues were boiled with 80% ethanol during 10 min in order to prepare the 
alcohol insoluble residues (AIR).  
Each AIR sample was submitted to a hot water extraction during 15 min at 100°C with an 
AIR/water ratio of 1:16 (w/v), and the insoluble material was separated from the soluble one by 
centrifugation. The extracted material was dialyzed against water with 12–14 kDa molecular weight 
cut off membranes. 
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2.1.1 Neutral sugar analysis 
Sugar composition of the polysaccharides was determined by gas chromatography-flame ionization 
detection (GC-FID) and quantified using 2-deoxyglucose as internal standard (Blakeney et al.,  
1983). Monosaccharides were released from polysaccharides (1–2 mg of sample) by pre-
hydrolysis in 0.2 ml of 72% H2SO4 for 3 h at RT followed by 2.5 h hydrolysis in 1M H2SO4 at 100°C 
(Selvendran, March, & Ring, 1979). 
Monosaccharides were reduced with NaBH4 (15% in 3 M NH3) during 1 h at 30°C and then 
acetylated, with acetic anhydride (3 ml) and 1-methylimidazole (450 µl), during 30 min at 30°C. 
The alditol acetates were separated by liquid-liquid extraction with water and dichloromethane and, 
after evaporation of the organic solvent, they were solubilized in 50 µl anhydrous acetone and 
analysed in a GC-FID Perkin Elmer-Clarus 400 with a capillary column DB-225 (30 m length, 0.25 
mm inner diameter and 0.15 µm film thickness). The oven temperature program was as follows: 
200°C to 220°C at a rate of 40°C/min (7 min), increasing to 230°C at a rate of 20°C/min (1 
min).  The temperature of the injector was 220°C and the detector was at 230°C. Hydrogen was 
used as carrier gas at a flow rate of 1.7 ml/min (Bastos et al., 2015; Pinto et al., 2015).  
!2.1.2 Glycosidic-linkage analysis 
The glycosidic-linkage composition was determined by gas chromatography-mass spectrometry 
(GC-MS) of partially methylated alditol acetates (Ciucanu & Kerek, 1984; Nunes & Coimbra, 2002). 
The samples (1 mg) were dissolved in 1 ml of anhydrous dimethylsulfoxide (DMSO), and then 
powdered NaOH (40 mg) was added under an argon atmosphere. The samples were methylated 
with CH3I (80 µl) during 20 min with stirring, followed by a second addition of 80 µl CH3I and 
stirring for another 20 min. CHCl3/CH3OH (1:1, 3 ml) was added and the solution was dialyzed 
(membrane with a pore diameter of 12–14 kDa) against 3 lots (1000 ml) of 50% ethanol. The 
dialysate was evaporated to dryness and the material was remethylated using the same procedure. 
The remethylated material was hydrolysed with 2 M trifluoracetic acid (TFA) (500 µl) at 120°C for 
1 h, and then reduced and acetylated as previously described for sugar analysis, using NaBD4 
instead of NaBH4. The partially methylated alditol acetates were separated and analysed by GC-
qMS using an Agilent Technologies 6890 N Network. The GC was equipped with a DB-1 (J&W 
Scientific, Folsom, CA, USA) capillary column (30 m length, 0.25 mm of internal diameter, and 
0.15 µm of film thickness). The samples were injected in “split” mode using an injector 
temperature of 220°C, during 5 min. The temperature program used was as follows: the initial 
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temperature was 50C, with a linear increase of 8°C/min until 140°C (5 min), followed by a linear 
increase of 0.5°C/min until 150°C and finally by a linear increase of 40°C/min until 250°C (1 
min). The helium carrier gas had a flow rate of 1.7 ml/min and a column head pressure of 14.4 
psi. The GC was connected to an Agilent 5973 mass quadrupole selective detector operating with 
an electron impact mode at 70 eV and scanning the range m/z 40–500, 1 s cycle, in a full scan 
mode acquisition (Bastos et al. 2015; Pinto et al. 2015). 
 
2.2 Determination of   -1,3 glucan exposure 
The exposition of β-1,3-glucans on the cell wall surface of C. bracarensis, C. glabrata, and S. 
cerevisiae was evaluated by flow cytometry analysis and immunofluorescence confocal microscopy 
upon incubation with an anti-β-1,3-glucan monoclonal antibody (mAb). 1x106 cells were incubated 
with anti-β-1,3 glucan mAb (Biosupplies) during 20 min at 4°C, and were stained with a anti-
mouse IgG conjugated with Alexa Fluor 488 (Molecular Probes, Invitrogen, USA)  for 20 min at 4°C 
in the dark. Cells were then washed with PBS, resuspended in FACS buffer (PBS; 1% BSA; 2 mM 
sodium azide), and analysed by flow cytometry (EPICS XL-MCL, Beckman-Coulter Corporation 
Miami, EUA). To unmask β-1,3-glucans, since these are usually localized in the inner layer of the 
cell wall and limitedly accessed (Brown et al., 2014) cells were heated-killed (HK), as previously 
described prior to staining. Flow cytometry data were analysed by using FlowJo software (version 
0.7- Treestar, Ashland, OR, USA).   
For immunofluorescence confocal analysis, stained yeasts were fixed with 4% paraformaldehyde 
(10 min, 37˚C), washed with PBS, and finally were mounted in coverslips with mounting medium 
(ibidi, Germany). The exposure of β-1,3-glucans was analysed under a laser scanning confocal 
microscope (Leica TCS SP5 II running LAS AF 2.6 software; Leica Microsystems, Germany) using a 
60x/1.40 numerical aperture (NA) oil immersion objective. Confocal microscopy images were 
analysed using FIJI- ImageJ software 2.00 (NIH-USA).  
 2.3 Quantification of yeast cell wall porosity: Polycations assay 
Overnight grown yeast cells were washed three times with distilled water. Yeasts (1x108) were 
incubated at 30 °C for 30 min at 250 rpm in 1 ml 10mM-Tris-HCl, pH 7.4 containing 10 µg poly-L-
Lysine (50 kDa) or 10 µg  DEAE-dextran.  As a control, cells were incubated in buffer without 
polycations. After incubation, the cells were centrifuged at 10000g for 10 min and the 
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supernatant’s absorvance (A260nm) was measured. Relative porosity was defined as (A260nm DEAE-
dextran – A260nm buffer) × 100/(A260nm poly-L-Lysine – A260nm buffer) (de Nobel et al,. 1990).      
 
3. Interaction of yeast with innate immune cells !
3.1 Macrophage culture 
The murine macrophage-like cell line RAW 246.7 was cultured in complete Dulbecco’s modified 
Eagle's medium (cDMEM) (Sigma Aldrich, USA) supplemented with 10% heat-inactivated FBS 
(invitrogen), 1% glutamine, 1% Penicilin-streptomycin, and 1% HEPES (all from Sigma Aldrich), at 
37 °C in a 5% CO2 humidified atmosphere. Sub-cultures were performed into new cell-culture 
flasks every 3 days. After confluent growth, macrophage cells were recovered and washed. Cell 
concentration and viability were determined by Trypan blue (Sigma Aldrich) exclusion counting with 
a hemocytometer, and resuspended in cDMEM to the desired final concentration. 
3.2 Human monocyte-derived macrophages 
Human peripheral blood mononuclear cells (PBMC) were obtained from buffy coats donated by 
healthy volunteers by gradient centrifugation using Histopaque-1077 (Sigma-Aldrich), according to 
manufacturer’s instructions. Then, monocytes were purified by magnetic cell sorting using CD14 
microbeads (Miltenyi Biotec, Germany). To differentiate PBMCs into monocyte-derived 
macrophages (MDMs), cells were resuspended at 1x106/ml in complete Roswell Park memorial 
institute (RPMI 1640) (Sigma Aldrich), supplemented with 10% autologous human serum, 1% 
penicillin-streptomycin, 1% HEPES buffer, 1% L-glutamine and 5 µM 2-mercaptoethanol (all from 
Sigma Aldrich), and platted in 24-well plates. Cells were incubated at 37°C with 5 % CO2 during 7 
days and the medium was renewed every three days. Adherent MDMs were then detached with 50 
mM EDTA, washed and counted before plating in flat-bottom 24-well plates in cRPMI at the desired 
concentration.  
3.3 Murine resident peritoneal macrophages 
Mice (BALB/c) were anesthetized with isoflurane before being euthanized by cervical dislocation. 
Upon brief immersion in 70% ethanol, 5 ml of ice cold PBS were injected into the peritoneal cavity 
using a syringe and a 18 G needle. After gentle massage, the peritoneal fluid was collected. The 
recovered murine resident peritoneal macrophages (RPMs) were counted in a hemocytometrer and 
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seeded in a 96-well-plates (flat bottom). !
3.4 Phagocytosis quantification assay 
The phagocytosis of all yeast strains by RAW 246.7 and MDMs was analyzed by using a new 
methodology described for yeast phagocytosis analysis by FACS (Carneiro et al., 2014). In brief, 
dead yeast cells (formol-ethanol fixed or heat killed), were incubated for 10 min with 5 µl of 1 µM 
Sytox Green (Invitrogen) at RT in the dark, washed twice with PBS to remove unbound dye and 
brought to the desired cell density in cDMEM. Macrophage cell suspensions (RAW, MDMs or 
RPMs) at final concentration of 5x105 cells/ml were transferred to 24-well tissue culture plates. 
Cells were then incubated during three hours, at 37 °C and 5% CO2, to allow macrophage 
adherence. Thereafter, phagocytic cells were washed twice with PBS to remove non-adherent cells 
and incubated with labeled yeast suspensions at a MOI of 1 Macrophage to 5 Yeasts (1M:5Y) for 
15 and/or 30 min, at 37 °C and 5% CO2. After incubation, wells were rinsed twice with warm PBS 
to remove unbound yeasts and plates were kept on ice to stop phagocytosis. Macrophages and 
associated yeasts were then incubated with 200 µl PBS and 10 µl Propidium iodide (PI; Sigma 
Aldrich), at a final concentration of 1 µg/ml, for 5 min at RT. Cells were washed with PBS to 
remove the excess of PI and lastly maintained in 300µl of FACS buffer. The cells were recovered 
by gently scrapping with insulin syringe plungers and analyzed by flow cytometry (EPICS XL-MCL, 
Beckman-Coulter Corporation Miami, EUA). Data were analysed by using FlowJo software (version 
10.0.7). The percentage of yeasts interacting with macrophages was calculated from dot plot 
analysis of Sytox Green fluorescence intensity vs. PI fluorescence intensity, as described by 
Carneiro et al., 2014.     
In order to determine phagocytosis rates of viable yeasts, macrophages seeded in 24-well plates as 
described before, were infected with live yeasts labeled with 100 µg/ml fluorescein isothiocyanate 
(FITC; Sigma Aldrich at a MOI of 1M:5Y and co-incubated for 30 min at 37°C and 5% CO2. Cells 
were stained with Tripan Blue (0,4 %) (Sigma Aldrich) right before analysis.  
This double staining procedure was accomplished in order to quenching PI or TB over Sytox Green 
or FITC labelled yeasts, respectively. As neither, PI or TB enters in viable cells, the internalized 
yeast cells will retain the original unquenched fluorescence.  
Alternatively, unstained live cells uptake was assessed by CFU counts after plating of the 
supernatants obtained by extensive washing of the yeast and macrophages co-cultures on YPD 
plates as follows: [(CFU of control well-CFU of test well)/ CFU of control well] x 100.  
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3.4.1 Blocking of phagocytosis receptors in RAW 246.7 and RPMs 
To block Mannan Receptor and Dectin-1, RAW 246.7 and RPMs were incubated with 500 µg/ml 
soluble mannan (from S. cerevisiae) and 3 µg/ml anti-mouse Dectin-1 mAb (clone 218820; R&D 
Systems, USA) or 500 µg/ml laminarin (Sigma Aldrich), respectively, in RPMI without serum 
during 30 min, at 37!°C, prior to addiction of yeasts.  
 
3.5 Determination of ROS production 
ROS production was measured by using the Superoxide Detection Kit  for flow cytometry (Enzo Life 
Sciences, USA). Viable yeast cultures were washed in PBS, ressuspended in cDMEM and co-
incubated with macrophages (MOI of 1M:5Y) previously seeded in 24-well plates. Plates were 
incubated at 37°C and 5% CO2 during 15, 30 and 60 min. As a positive control, macrophages 
were treated with 100 nM PMA (Sigma-Aldrich). After the incubation period, media were removed 
and cells were washed twice with Wash Buffer (supplied with the kit). Cells were detached from the 
tissue culture plates, as described above, collected and centrifuged for 5 min at 400 g at RT.  
Lastly, the cell pellet was resuspended in 300 µl of superoxide staining solution during 30 min at 
37°C in the dark. Samples were immediately analyzed by flow cytometry and data was analysed by 
using FlowJo software (version 10.0.7).  Results are presented as the normalized percentage of 
ROS positive cells, considering that PMA stimulated 100% ROS production in macrophages. 
 
3.6 Interaction between yeast and bone marrow derived dendritic cells 
(BMDC) and bone marrow macrophages (BMM)  
 
3.6.1 Mice 
Male BALB/c and C57BL/6 mice, 8 to 10 weeks old, were purchased from Charles River (Saint-
Germain-sur-l’Arbresle, France) and kept under specific-pathogen-free conditions at the Animal 
Facility of the Instituto de Ciências Biomédicas Abel Salazar, Porto, Portugal. All procedures 
involving mice were performed according to the European Convention for the Protection of 
Vertebrate Animals Used for Experimental and Other Scientific Purposes (ETS 123), the 
86/609/EEC directive, and Portuguese rules (DL 129/92).!
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3.6.2 Differentiation of BMDC and BMM  
Mice (BALB/c or C57BL/6) were anesthetized with isoflurane before being euthanized by cervical 
dislocation. Upon brief immersion in 70% ethanol, femurs and tibias were removed under aseptic 
conditions and flushed with cold Hank’s balanced salt solution (HBSS) (Sigma Aldrich), in order to 
obtain undifferentiated bone marrow cells. The resulting cell suspension was passed through a 70 
µm pore filter, centrifuged at 300 g, and resuspended in cRPMI medium. To remove fibroblasts or 
differentiated macrophages, cells were incubated on Petri dishes, during 5 hours at 37°C in a 5% 
CO2 humidified atmosphere. Then, non-adherent cells were collected with warm cRPMI, counted in 
a hemocytometer, brought to a final concentration of 1x106 cell/ml, in the appropriate medium, 
promptly seeded 5 ml of cell suspension per well in 6-well plates, and incubated at 37°C with 5 % 
CO2 for 7 days. cRPMI was supplemented with 20% J558-conditioned-supernatant (containing 
murine granulocyte-macrophage colony-stimulating factor (GM-CSF)) to differentiate cells into 
BMDC and medium was renewed every two days. To differentiate into BMM, cRPMI was 
supplemented with 10% L-cell conditioned medium (LCCM), the cultures were further 
supplemented at day 3 with 10% LCCM and medium was renewed at day 5.  
Purity of derived DC’s and macrophages was accessed upon staining with anti-mouse CD11c FITC-
conjugated, (clone HL3) (BD Pharmingen), anti-mouse F4/80-PE-Cy5-conjugated, (clone BM8) 
(eBioscience), anti-mouse MHCII PE-conjugated (I-Ad/I-Ed, clone 2G9) (BD Pharmingen), anti-
mouse CD86 PE-Cy7-conjugated, (clone GL1) mAb, and determined by flow cytometry. 
3.6.3 Dectin- 1 blockage in BMDC and BMM  
The blocking of the C-type lectin Dectin-1 in BMDC and BMM was done by incubation with 3 µg/ml 
anti-mouse Dectin-1 mAb (clone 218820; R&D systems), 1 hour prior to co-incubation with yeast 
cells.  
3.6.4 Co-incubation of BMDC and BMM with C. bracarensis, C. glabrata and S. 
cerevisiae strains 
After the 7-day-incubation period, BMDC and BMM were carefully recovered, washed with cRPMI, 
counted, and seeded in 96-well-plates (round and flat bottom, respectively).  
Viable yeast cells were incubated with BMDC and BMM at a MOI of (1M:5Y) and (1M:2Y), and the 
plates were incubated during 24 hours at a 37°C and 5% CO2. LPS (2 µg/ml, Sigma Aldrich) and 
unstimulated cells were used as positive and negative controls respectively. After the infection 
 ! 37!
period, the plates were centrifuged at 400 g during 10 min and supernatants were recovered and 
stored at -80°C until cytokine quantification. 
 
3.6.5 Cytokine quantification by sandwich ELISA 
The amount of IL-1β, IL-10, IL-12p40, IL-23 secreted by BMDC was determined by sandwich ELISA 
according to the manufacturer’s instructions (Mouse IL-1β ELISA Ready-SET-Go!®;  Mouse IL-
12p40 ELISA Ready-SET-Go!®; Mouse IL-23 ELISA Ready-SET-Go!®, all from eBioscience, San 
Diego, EUA and Mouse IL-10 DuoSet ELISA Development System - R&D systems). All experiments 
were performed in triplicate. TNF-α levels were detected in the supernatants of both BMDCs and 
BMMs by ELISA using the Mouse TNF- α ELISA Ready-SET-Go!®, eBioscience. 
 
3.6.6 Evaluation of bone marrow dendritic cells activation 
For the assessment of cell surface activation markers, BMDCs were collected from the culture 
plates 24 h after yeast incubation, washed in FACS buffer and incubated with specific cell surface 
antibodies, anti-CD11c-FITC conjugated (clone HL3), anti-CD80-PE conjugated (clone 16-10A1), 
CD86-PECy7 conjugated (clone GL1) and MHC class II- PerCP conjugated (clone 2G9), all from 
eBiosciences. 
. 
4. Isolation of mouse peritoneal cavity cells !
4.1 Mice yeast infection and analysis of peritoneal cavity cells 
To investigate the recruitment of myeloid cells at the site of yeast infection, sixteen BALB/c mice 
were infected intraperitoneally (i.p.) with 1 x 107cells of selected yeast strains in 0.4 ml PBS. 
Control mice were injected i.p. with PBS. 
After 4, 6 or 72 hours of infection the animals were euthanized and 5 ml of ice cold PBS were 
injected into the peritoneal cavity using a syringe and a 18 G needle. After gentle massage, the 
peritoneal fluid was collected.  
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For cell surface marker staining, 1x106 of peritoneal isolated cells were incubated with anti-mouse 
CD16/CD32 (Fc Block; 1:100) at 4°C for 15 minutes and then stained for 25 minutes with the 
appropriate antibody cocktails at previously optimized concentrations: anti-mouse GR-1 (Ly6C and 
Ly6G) FITC-conjugated, (clone R86-8C5; BD Pharmingen); anti-mouse integrin αM, Mac-1 α chain 
CD11b PE-conjugated, (clone M1/70; BD Pharmingen); anti-mouse F4/80 PE-Cy5-conjugated, 
(clone BM8; eBioscience); anti-mouse MHCII PE-conjugated, (clone 2G9; BD  Pharmingen). After 
washing with FACS buffer, samples were analyzed by flow cytometry.  
 
5. Statistical Analysis 
All experiments were performed at least in triplicate (n≥3). All data were reported as means ± SD. 
Data were analysed by One-way ANOVA and Bonferroni post-Hoc test using GraphPad Prism 
(Version 5.00 for Windows) or using unpaired two-tailed t-test. Statistically significant results were 
defined as follows: *P<0.05, **P<0.01, and ***P<0.001, ****P<0.0001.  
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1.Phenotypic characterization of C. bracarensis, C. glabrata and S. cerevisiae 
strains  !
1.1 Yeast  identification!
A yeast collection comprising 15 strains, five of each studied species, C bracarensis, C glabrata 
and Saccharomyces cerevisiae, was used here. Additionally, a well characterized C. albicans strain 
(SC5314) was used in specific experiments. In order to verify if all strains used in this study were 
properly identified, species identification was done by ITS-DNA sequencing followed by BLAST 
search of the ITS sequences in the NCBI GenBank database, thus confirming the identity of all 
strains used. 
 
1.2 Sap production!
The secretion of hydrolytic enzymes during infection represents one of the major virulence factors 
in C. albicans, since it facilitates invasion and colonization of tissues of the host by disrupting host 
membranes (Naglik et al., 2003). Among these, secreted aspartyl proteases (Sap) have been the 
most extensively studied. It was reported that C. glabrata was not able to produce Sap (Ashour et 
al., 2015), and very recently, C. bracarensis was shown to secrete very low levels of Sap (Moreira 
et al., 2015). 
C. bracarensis and C. glabrata strains were cultured for 11 days in YCB-BSA plates at 30°C 
followed by staining with amido black that binds and stains proteins with a dark blue color. As 
shown in Figure 4, only C. albicans (A) was surrounded by a halo without staining, corresponding 
to degraded BSA, caused by the production of Saps. The remaining strains showed no halo around 
themselves, which indicates lack of Sap production. Cultures incubated at 37°C were equally 
stained, and the obtained result was analogous to that shown in Figure 4. 
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Figure 4: Evaluation of Sap production by C. glabrata and C. bracarensis strains in YCB-BSA 
medium stained with amido black. Images were captured after 11 days of growth at 30°C. C. albicans 
was used as a positive control. A- C. albicans SC5314, B- C. glabrata hemo117, C- C. bracarensis CL-
7030, D- C. bracarensis 445L, E- C. bracarensis NCYC 3133, F- C. glabrata CBS 138, G- C. bracarensis 
246188, H- C. glabrata CIPO88, I- C. bracarensis 153M. 
 
 
 
1.3 Filamentous grown 
Virulence factors such as filamentation contribute to Candida pathogenesis and hyphae appear to 
be more invasive than the yeast form in several species of the genus Candida (Brunke and Hube, 
2013). For this reason we tested all C. glabrata and C. bracarensis strains in what concerns 
filamentation ability. As described in literature (Mayer et al., 2013; Si et al., 2013) C. albicans was 
able to filament in all media tested. On the opposite, C. glabrata and C. bracarensis strains did not 
filament in any of these culture conditions (Figure 5). 
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Figure 5: Candida strains cultured in different filamentation induction media. Images were 
captured after 10 days of growth at 37°C in I- SLAD medium, II- Spider medium, III- YPD+10%FBS 
medium. A- C. albicans SC5314, B- C. bracarensis CL-7030, C- C. bracarensis 445L, D- C. glabrata 
hemo1117, E- C. glabrata CBS 138. 
 
 !
1.4 Resistance to oxidative, osmotic, and cell wall stress agents 
In order to evaluate the response of C. bracarensis, C. glabrata, and S. cerevisiae to different 
environmental conditions and stressors, each strain was cultured in medium supplemented with 
several stress agents, such as cell wall stress agents SDS, caffeine, calcofluor white (CFW), 
caspofungin, and congo red; the osmotic stress agent NaCl; and the oxidative stress agent 
hydrogen peroxide (H2O2). Three strains of each species were tested generally displaying 
susceptibility patterns similar to those shown in Figure 6. Only results of the highest doses tested 
for each stress agent are shown. 
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Figure 6: Growth of C. bracarensis 153M, C. glabrata CIPO88 and S. cerevisiae L559 strains 
in medium supplemented with different stress agents. Serial 10-fold dilutions in YPD overnight 
cultures were spotted on YPD plates with: 0,15% SDS , 20 mM caffeine, 250 µg/ml calcofluor white, 180 
µg/ml caspofungin, 250 µg/ml congo red or 2 M NaCl, as indicated. Susceptibility to hydrogen peroxide 
was accessed upon a 3 hour incubation period, of the overnight cultures, in YPD suplemented  with 50 mM 
H2O2. Serial dilutions were then platted in YPD plates. All plates were incubated for 48h at 30°C or 37°C. 
Culture plates without any stressor were used as controls (YPD). 
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C. glabrata showed reduced susceptibility to SDS, both at 30°C and 37°C, an indicator of cell wall 
integrity (Turmachev et al., 1994). On the contrary, C. bracarensis failed to grow in these 
conditions.  
Caffeine is also a cell wall stress agent, and the mechanism by which it induces cell wall stress is 
not yet clearly understood (Levin, 2011). All species were somewhat affected by caffeine, although 
C. glabrata presented higher tolerance when cultured at 37°C in comparison to C. bracarensis and 
S. cerevisiae. CFW is a well characterized wall stressor agent. It binds to chitin of fungal cell walls. 
It is responsible for cell wall integrity disruption and entails different mechanisms of inhibition 
(Kingsbury et al., 2012). Hereupon, it was clear that C. glabrata was not affected by CFW contrary 
to what was observed in C. bracarensis and S. cerevisiae. 
Caspofungin is one of the most used echinocandin drugs in clinical practice. Caspofungin is a 
lipopeptide that inhibits the activity of β--1,3--glucan synthase affecting cell wall assembly (Rueda et 
al., 2014). All species were affected by this echinocandin at different extents. Interestingly, C. 
bracarensis and C. glabrata were more sensitive to caspofungin when incubated at 30°C than at 
37°C. Conversely, S. cerevisiae was far more sensitive to the drug at 37°C than at 30°C. 
Noteworthy, although C. glabrata and C. bracarensis presented similar tolerance to caspofungin at 
37°C, at 30°C however C. bracarensis growth in the presence of caspofungin was considerably 
more affected than that of C. glabrata. 
Furthermore, C. glabrata was the only species which grew without limitation in medium 
supplemented with congo red, that despite interacting with various polysaccharides, exhibit a 
particularly high affinity for chitin and β-glucans (Nodet et al., 1990).  Susceptibility to NaCl was 
related with poor osmotic adaptation and reduced membrane fluidity (Khaware et al., 1995). C. 
bracarensis and C. glabrata had similar susceptibility to NaCl 2M, however S. cerevisiae was 
considerably more susceptible to this osmotic stress agent.  
Incubation with 50 mM hydrogen peroxide, in these experimental conditions, did not cause any 
growth limitation in C. glabrata, C. bracarensis, and S. cerevisiae.    
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2. Cell wall characterization!
2.1 Sugar analysis and glycosidic linkage analysis 
Although the interactions between cell wall glucans and immune cells have been widely 
investigated (Ruiz-Herrera et al., 2006; Hall, 2015), how the different polysaccharides are 
organized and how this distribution varies from species to species is yet poorly understood. In line 
with that, the neutral sugar composition and glycosidic linkage of the cell wall of C. bracarensis, C. 
glabrata, and S. cerevisiae were evaluated by using GC-FID and GC-MS, respectively.  
Sugar analysis (Table 2) of AIR showed that C. bracarensis was composed by approximately 59 
molecular percentage (mol%) of glucose and 37 mol% of mannose. C. glabrata presented 
approximately 59 mol% of glucose and 38 mol% of mannose while S. cerevisiae was composed by 
approximately 54 mol% glucose and 42 mol% mannose. The remainded mol%, approximately 4 %, 
was related with xylose, arabinose and ribose fractions content. The results obtained of the water 
extraction residues revealed similar results, without significant differences among the species in 
study.  
Contrarily to the results obtained in the sugar analysis, the glicosidic-linkage analysis (Table 3) 
demonstrated significant differences among species, especially between C. bracarensis and C. 
glabrata. C. bracarensis presented a higher content of β-1,3-glucan relatively to other samples 
studied. In contrast, the content of α -1,2-mannose was higher in C. glabrata and S. cerevisiae. 
The differences found between the total molar percentage of sugar analysis and glycosidic linkage 
analysis were related to the structure of mannoproteins. The mannoproteins of the studied yeasts 
have shorter chains, and more terminal branches. For such smaller structures, the hydrolysis 
performed using 1M sulphuric acid is awfully drastic to mannan oligomers, leading to their 
degradation. The hydrolysis with TFA performed in glycosidic linkage analysis is less aggressive 
minimizing, on the one hand, the degradation of smaller polymers and ensuring, on the other 
hand, the hydrolysis of larger polymers.  
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Table 2: Neutral sugar analysis of C. bracarensis, C. glabrata and S. cerevisiae: Yeast carbohydrate composition of yeast fractions obtained by AIR and 100°C 
water extraction. Mean results are presented in mass concentration and molecular concentration. Each condition was set in triplicate.  
Rib- Ribose, Ara-Arabinose, Xyl- Xylose, Man-Mannan, Glc- Glucose. 
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Table 3: Yeast glycosidic linkage composition (molecular %) of sequencial extraction (AIR and 100°C water).  
The glycosidic-linkage composition was determined by GC-MS of partially methylated alditol acetates. Xyl- Xylose; Man- Mannan; Glc- Glucose
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2.2 Determination of  -1,3 glucan exposure 
The exposition of β-1,3-glucans on the cell wall surface of C. bracarensis, C. glabrata, and S. 
cerevisiae was evaluated by flow cytometry upon incubation with an anti-β-1,3-glucan monoclonal 
antibody (mAb). β-1,3-glucans are usually localized in the inner layer of the cell wall and limitedly 
accessed (Brown et al., 2014). To unmask this polysaccharide and increase antibody recognition, 
cells were HK at 70°C for 30 minutes.  
As can be observed in Figure 7, the mean fluorescence intensity (MFI), due to β-1,3-glucan 
staining, is markedly higher in C. bracarensis than in the other species indicating that higher 
antibody recognized epitopes were available in the former species. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7: Determination of β-1,3 glucan exposed content in C. bracarensis, C. glabrata, S. 
cerevisiae  and C. albicans cell wall.  Yeasts were incubated with an anti-β-1,3-glucan mAb , revealed 
with an anti-mouse IgG conjugated with Alexa Fluor 488, and analysed by flow cytometry (A), and confocal 
microscopy (B). Bars correspond to means plus one SD. One-way ANOVA with Bonferroni post-Hoc test.  C. 
bracarensis n=3; C. glabrata n=3; S. cerevisiae n=3 and C. albicans n=1 (*P<0,05; ** P<0,01). 
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Heat-killed yeasts had slightly increased β-1,3-glucan exposure in all species, maintaining the same 
trend observed for viable yeasts. In accordance, C. bracarensis yeasts showed a significantly 
brighter signal than C. glabrata, S. cerevisiae, and also C. albicans, when stained with anti-β-1,3-
glucan mAb, and analyzed by confocal microscopy (Figure 7). 
 
 
2.3 Determination of yeast cell wall porosity: Polycations assay  
The ability of the cell wall to protect the yeast by limiting access to outside molecules also provides 
a potential barrier to diffusion of fungal products (Harris et al., 2009; Ene et al., 2012). Given the 
major impact on cell wall architecture, the wall porosity was investigated using an assay based on 
the polycation-induced leakage of UV-absorbing compounds from cells (Table 4). This assay 
compares leakage induced by small polycations (poly-L-lysine, 50 KDa) with the release caused by 
large polycations, such as DEAE-dextran (500 KDa). Disturbance of the cell membrane by DEAE-
dextran highly depends on the degree of porosity of the cell wall (De Nobel et al., 1990). 
  
Table 4: Effect of polycations on C. bracarensis, C. glabrata, S. cerevisiae, and C. albicans 
cell membrane. Absorbance values with DEAE-Dextran and Poly-L-lysine treatment  and percentage of 
relative cell wall porosity ± SD. One-way ANOVA with Bonferroni post-Hoc test.  C. bracarensis n=3; C. 
glabrata n=3; S. cerevisiae n=3 and C. albicans n=1 (**** P<0.0001) C. bracarensis vs other yeast species. 
 
  
 Cell leakage (A260nm) Relative porosity 
(%) 
 
 
Yeast 
DEAE-dextran 
500 KDa 
Poly L-Lysine 
50 KDa 
C. bracarensis 0,121 0,138 68,9 ± 3,1**** 
C. glabrata 0,013 0,116 2,2 ± 0,8 
S. cerevisiae 0,019 0,056 3,2 ± 0,4 
C. albicans 0,037 0,070 4,6 ± 3,1 
 
 
The cell wall relative porosity of C. bracarensis was more than tenfold higher than that of C. 
glabrata and S. cerevisiae. Increased UV-absorving compound release to the extracellular 
environment was induced by DEAE-dextran in C. bracarensis, when compared with any of the other 
species.  Increased porosity has been previously associated with short mannan side-chains (Ene et 
al., 2012). Thus, these values of C. bracarensis cell wall porosity are in accordance with the results 
described above related to the cell wall composition. 
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3. Quantification of yeasts phagocytosis by macrophages!
Phagocytosis plays a critical role in innate immunity, facilitating the removal and killing of 
pathogens, and priming the adaptive immune response (Rubin-Bejerano, 2007; Romani, 2011). 
The phagocytic process is initiated by the cross-linking of an array of surface receptors, some 
capable of direct recognition and others that recognize opsonins coating the pathogen (Herre et al., 
2004).  
Phagocytosis assays were first performed in RAW 246.7 macrophages incubated with heat-killed 
(HK) yeasts and C. glabrata was phagocytosed at higher rates than C. bracarensis and S. 
cerevisiae. S. cerevisiae was the least phagocytosed species (Figure 8 B). To evaluate if the 
method used to inactivate yeasts could influence their recognition by macrophages and thus 
impact on the phagocytosis rate, fixed yeasts were incubated with RAW 246.7 macrophages and 
regardless of the method used to inactivate the cells, C. glabrata was still the most phagocytosed 
species while S. cerevisiae was the least phagocytosed (Figure 8 C). Since sugar cell wall 
composition was performed in yeast cells grown in Sabouraud medium, the assay referred above 
for HK yeast cells was also performed in cells grown in Sabouraud medium to confirm that growth 
in Sabouraud did not affect yeast phagocytosis by macrophages. The results obtained were similar 
to those seen with yeast cells grown in YPD, thus confirming that growth in the absence of yeast 
extract did not greatly affect phagocytosis (Figure 8 D). The phagocytosis rates of the different yeast 
species were also determined in human monocyte-derived macrophages. Similarly to what had 
been observed with RAW 246.7 macrophages, C. glabrata cells were engulfed at a greater extent 
by MDMs and once again S. cerevisiae was the least internalized species (Figure 8 E).   
To evaluate if viable yeast cells could interfere with the phagocytosis process, phagocytosis assays 
were performed using viable yeast cells and the results were analyzed by flow cytometry (Figure 9 
A) and CFU counts (Figure 9 B). C. glabrata remained the most phagocytosed species and S. 
cerevisiae was internalized at lower rates than the other species. However, the statistical 
significance of the differences in the phagocytosis rates between C. glabrata and C. bracarensis 
found when using HK or fixed yeast cells were lost.  
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Figure 8: Phagocytosis of killed C. bracarensis, C. glabrata and S. cerevisiae  Quantification of 
yeast phagocytosis by macrophages was assessed by flow cytometry. Macrophages (MΦ) were incubated 
for 30 min with inactivated yeasts labelled with Sytox Green and stained with Propidium Iodide prior to 
analysis (A) Representative FACS examples. After gating the macrophage population (left) the quantification 
of four sub-populations was performed (right) Q1: MΦ only with internalized yeasts; Q2: MΦ with 
internalized and adhered yeasts; Q3: MΦ only with adhered yeasts; Q4: MΦ without interaction with yeasts.  
RAW 246.7 murine macrophage cell line phagocytosis percentage of (B) HK yeasts grown in YPD medium, 
(C) fixed (formol-ethanol) yeasts grown in YPD media and (D) HK yeasts grown in Sabouraud medium. 
Phagocytosis assays of HK yeasts, grown in YPD medium, were also performed with human monocyte-
derived macrophages (E). Each condition was set in triplicate. Bars represent means plus one SD. One-way 
ANOVA with Bonferroni post-Hoc test: n=5 per yeast species in RAW 246.7 phagocytosis assays and n=3 
per yeast species in human monocyte-derived macrophage assays (*P<0,05; ** P<0,01; *** P<0,001; 
****P<0,0001). 
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Figure 9: Phagocytosis of viable C. bracarensis, C. glabrata and S. cerevisiae Quantification of 
yeast phagocytosis by RAW 246.7 macrophage cell line was assessed by flow cytometry (A) and by CFU 
counting (B). For FACS analysis MΦ were incubated during 30 min with viable yeasts labelled with FITC 
and stained with Trypan Blue right before analysis. Representative FACS examples are shown on the left. 
Q2: MΦ with internalized yeasts; Q3: MΦ without interaction with yeasts. Alternatively, unstained live yeasts 
uptake was assessed by CFU counts after plating of the supernatants obtained by extensive washing of the 
yeast/macrophage cultures on YPD plates. Each condition was set in triplicate. Bars represent means plus 
one SD. One-way ANOVA with Bonferroni post-Hoc C. bracarensis n=2; C. glabrata n=2; S. cerevisiae n=2 
(*P<0,05; *** P<0,001). 
 
 
Taking into account the different experimental conditions tested, C. glabrata was generally more 
efficiently internalized by macrophages than its closely related species C. bracarensis and S. 
cerevisiae 
Given that C. glabrata, C. bracarensis, and S. cerevisiae had different cell wall composition, distinct 
exposure of β-1,3-glucans, and unique susceptibility patterns to several cell wall stress agents, 
here we tried to block recognition/signalling by specific host phagocytic receptors that could be 
differentially interacting and internalizing yeasts. Thus, murine macrophages (RAW 246.7 cell line 
FI
TC
Trypan Blue
A
B
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and resident peritoneal macrophages) were incubated with soluble mannan or laminarin (a β-1,3-
glucan) prior to culture with viable yeast cells to block the mannose receptor and dectin-1 receptor, 
respectively. Addicionally, specific Dectin-1 blockage was done by treating macrophages with an 
anti-mouse Dectin-1 mAb before adding the yeast cells. RAW macrophages were also treated with 
anti-mouse/human CR3/CD11b in order to block CR3 receptor. Incubation with soluble mannan 
and anti-CR3/CD11b did not affect significantly the phagocytosis rates of any yeast species by 
RAW 246.7 macrophages (Figure 10 A). In this macrophage cell line, blockage of dectin-1 using 
laminarin did not affect the uptake rates of C. bracarensis, but clearly reduced the phagocytosis 
rates of the other yeast species by RAW 246.7 macrophages, particularly of S. cerevisiae (Figure 
10 A). Blockage of the Dectin-1 receptor with anti-mouse Dectin-1 mAb confirmed in general the 
results obtained by dectin-1 blockage with laminarin, nevertheless, uptake of C. bracarensis was 
reduced upon blocking mAb treatment (Figure 10 A). Curiously, S. cerevisiae was phagocytosed at 
higher rates by RPMs than C. bracarensis. Even so, C. glabrata remained the most internalized 
species (Figure 10 B). In general, the effect of laminarin treatment on RPMs phagocytosis was 
similar to the one observed on RAW 246.7 macrophages. Intringuingly, when RPMs were pre-
treated with anti-mouse Dectin-1 mAb, no changes in the phagocytosis rates could be observed for 
any of the yeast species tested (Figure 10 B).   
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Figure 10: Phagocytosis of viable C. bracarensis, C. glabrata and S. cerevisiae with or 
without PRRs signaling inhibitors. Quantification of yeast phagocytosis by RAW 246.7 macrophage cell 
line and murine resident peritoneal macrophages was assessed by flow cytometry For FACS analysis MΦ 
were incubated during 30 min with viable yeasts labelled with FITC and stained with TB right before 
analysis. RAW 246.7 were incubated with soluble mannan (500 µg/ml),  laminarin (500 µg/ml),  anti-
mouse Dectin-1 mAb (3 µg/ml) and with anti-mouse/human CD11b/CR3 (20 µg/ml) 30 min prior infection 
with yeasts (A). Inhibition of murine resident peritoneal macrophages by Laminarin or Anti-Dectin-1 mAb (B) 
was similarly performed. Bars represent means plus one SD. Unpaired two-tailed t-test C. bracarensis n=2; 
C. glabrata n=2; S. cerevisiae n=2 (** P<0,01). 
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4. Determination of Reactive Oxygen Species production by macrophages 
 
Phagocytes play a crucial role in the host response to fungi and the production of reactive oxygen 
metabolites is a key event following phagocytosis (Nathan and Shiloh, 2000; Seider et al., 2014 
being considered a major antifungal mechanism in phagocytes (Cheng et al., 2012). Both C. 
albicans and C. glabrata produce enzymes and molecules to evade oxidative killing, which may 
represent an important immune evasion mechanism (Seider et al., 2014). For that, we examined 
the ability of C. bracarensis, C. glabrata and S. cerevisiae to induce and modulate phagocyte ROS 
production. 
As presented in Figure 11 A, C. glabrata and C. bracarensis stimulated similar ROS production by 
RAW 246.7 macrophages. On the other hand, S. cerevisiae induced the lowest levels of ROS.  
Figure 11: Production of ROS by murine macrophages ROS quantification was assessed by using a Superoxide 
detection Kit. Macrophages were incubated for 15, 30 and 60 min with live (A) or HK (B) yeasts and analysed by flow 
cytometry. Results were normalized to macrophages stimulated  with PMA (positive control). Each condition was set in 
triplicate. Means ± one SD are presented. One-way ANOVA with Bonferroni post Hoc test  C. bracarensis n=5; C. 
glabrata n=5; S. cerevisiae n=5 (+++/***P< 0,001; ++++/**** P<0,0001) * S. cerevisiae vs. C. bracarensis; + S. cerevisiae 
vs. C. glabrata. 
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Interestingly, when this assay was performed with heat-killed yeasts, the three species stimulated 
equivalent ROS production and higher percentages of macrophages were ROS positive when 
compared with macrophages incubated with viable yeasts (Figure 11 B). 
 
 
5. Quantification of cytokine production by sandwich ELISA  !
Following the recognition of pathogens by PRR, distinct signalling pathways are induced. These 
pathways act through a cross-regulation mechanism, which results in the production of 
proinflammatory cytokines (Mogensen, 2009).   
The induction of proinflammatory cytokines is an important component of anti-Candida host 
defence (Ifrim et al., 2014). Thus, the levels of the cytokines IL-12, TNF-α, IL-1β, IL-23, and also of 
the anti-inflammatory cytokine IL-10 were quantified in the culture supernatants of BMDCs and 
BMMs from BALB/c (Figure 12) and C57BL/6 (Figure 13) mice stimulated with C. bracarensis, C. 
glabrata and S. cerevisiae at two different multiplicities of infection. Supernatants from BMDCs 
incubated with medium alone or with LPS were used as negative and positive controls, 
respectively, though the results were omitted in the graphs for simplicity. 
C. bracarensis induced higher production of proinflammatory cytokines such as IL-12p40, IL-23, IL-
1β, and TNF-α, by BMDCs of BALB/c mice regardless of the multiplicity of infection. Globally, C. 
glabrata was the species that induced the lowest levels of the proinflammatory cytokines referred 
above. Curiously, S. cerevisiae was the species that stimulated the highest levels of IL-10. C. 
glabrata induced the lowest levels of this anti-inflammatory cytokine by BMDCs (Figure 12). 
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Figure 12: Quantification of cytokines in the supernatants of BMDCs from BALB/c mice. 
The levels of IL-10 (A), IL-12p40 (B), IL-23 (C), TNF-α (D), and IL-1β (E) secreted by BMDC from BALB/c 
mice were quantified by sandwich ELISA. BMDCs were incubated with viable yeast cells at a MOI of 1:5 (1 
DC/Mo: 5 yeast cells) or at a MOI of 1:2, as indicated, for 24h. The supernatants were collected and the 
referred cytokines were quantified. Each condition was set in triplicate. Bars correspond to means plus SD. 
One-way ANOVA with Bonferroni post Hoc test.  C. bracarensis n=5; C. glabrata n=5; S. cerevisiae n=5 
(*P<0,05; ** P<0,01; *** P<0,001; **** P<0,0001). 
 
 
 
The profile of cytokines produced by BMDCs from C57BL/6 mice, upon incubation with the yeasts, 
was in general very similar to the one found in BMDCs from BALB/c mice. As presented in Figure 
13, C. bracarensis stimulated the production of the highest concentrations of the proinflammatory 
cytokines Il-23, IL-1β and TNF-α. The Th1 driving cytokine 12p40 levels were also found increased 
in BMDCs incubated with C. bracarensis, despite not being statistically significant. Additionally, no 
significant differences in the levels of IL-10 were found among the supernatants of BMDCs 
incubated with any of the studied yeast species (Figure 13).  
Overall, despite small differences between mice strains, the profile of cytokines was quite 
concordant. C. bracarensis induced the highest concentration levels of proinflammatory cytokines, 
with particular emphasis on IL-23 and TNF- α.  
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Figure 13: Quantification of cytokines in the supernatants of BMDCs from C57BL/6 mice. 
The levels of IL-10 (A), IL-12p40 (B), IL-23 (C), TNF-α (D), and IL-1β (E) secreted by BMDC from BALB/c 
mice were quantified by sandwich ELISA. BMDCs were incubated with viable yeast cells at a MOI of 1:5 (1 
DC/Mo: 5 yeast cells) or at a MOI of 1:2, as indicated, for 24h. The supernatants were collected and the 
referred cytokines were quantified. Each condition was set in triplicate. Bars correspond to means plus SD. 
One-way ANOVA with Bonferroni post Hoc test.  C. bracarensis n=3; C. glabrata n=3; S. cerevisiae n=3 
(*P<0,05; ** P<0,01; *** P<0,001). 
 
  
 
 
5.1. Effect of Dectin-1 and CR3 blockage on TNF-α  production  
 
PRRs, such as TLRs and C-type lectin receptors, particularly Dectin-1, are essential determinants of 
host antifungal immunity. The recognition of β-glucans by Dectin-1 has been shown to mediate cell 
activation, cytokine production, and a variety of antifungal responses (Carvalho et al., 2012).  
Given that C. bracarensis allowed greater access to cell wall β-1,3-glucans, dectin-1 and/or CR3 
could be recognizing those carbohydrates and contributing to the high levels of proinflammatory 
cytokines detected in BMDCs incubated with that yeast species. Thus, Dectin-1 and also CR3 
blockage was attempted in BMDCs and BMM infected with the different yeast species, and TNF-α 
levels were determined in the supernatants of the cultures to assess the involvement of Dectin-1 
and CR3 in the inflammatory response to yeasts. As expected, production of TNF-α induced on 
both BMDCs and BMMs by C. bracarensis was clearly affected by blockage of Dectin-1 receptor, 
irrespective of the multiplicity of infection used. Conversely, TNF-α production was not adversely 
affected in BMDCs or BMMs infected with C. glabrata or S. cerevisiae. Interestingly, C. albicans-
induced TNF-α production by BMMs, but not by BMDCs, was reduced upon blockage of Dectin-1 
(Figure 14).  
CR3 blockage did not have a detrimental effect on C. bracarensis-induced TNF-α production. On 
the opposite, an increase in the production of TNF-α was indeed observed, not only in BMDCs and 
BMMs cultured with C. bracarensis, but also in those incubated with C. glabrata and S. cerevisiae. 
Curiously, CR3 blockage had a strong negative impact on TNF-α production by BMDCs and BMMs 
infected with C. albicans (Figure 14)%%% 
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Figure 14: Quantification of TNF-α in the supernatants of BMDC and BMM from BALB/c mice 
without or with CR3, Dectin-1 blockage. BMDCs and BMMs were incubated with the different viable 
yeast strains at a MOI of 1:2 and 1:5 (1 DC/Mo: 2 and 5 yeast cells, respectively) for 24h. To block dectin-1 
and CR3 signaling, anti-mouse Dectin-1 mAb (3µg/ml) and anti-mouse/human CR3 mAb (20µg/ml) were 
added 30 min prior to infection. The supernatants were collected and the levels of TNF-α were quantified by 
sandwich ELISA. Results are from a single experiment set in duplicate. Bars correspond to means plus SD. 
Unpaired two-tailed t-test was performed to compare, within each species, results from unblocked cultures 
with results from anti-Dectin-1 or anti-CR3 blocked cultures; A single strain of each yeast species was used 
(*P<0,05; ** P<0,01). 
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6. Evaluation of bone marrow derived dendritic cells activation/maturation !
The role of DCs in T cell activation and in the initiation of antigen-specific immune responses is 
very well documented. During infection, DCs in the periphery are triggered by exposure to microbial 
agents or inflammatory mediators to increase their expression of major histocompatibility complex 
(MHC) molecules and co-stimulatory molecules such as CD80 and CD86. This activates peripheral 
DCs into a state ready for T cell activation (Guermonprez et al., 2002; Granucci et al., 2004).  
Activated DCs then display pathogen-encoded antigens to naive antigen-specific T cells, which 
respond and initiate primary T cell immune responses (Tan and O’Neill, 2005). 
In order to evaluate the activation/maturation status of BMDCs after 24h of infection with yeasts, 
the cell surface expression of MHC class II, CD86, and CD80 activation markers was analyzed by 
flow cytometry upon staining with specific mAbs.  All yeast species induced the maturation of 
BMDCs when compared with non-stimulated BMDCs (Figure 15 A). C. bracarensis, right after C. 
albicans, induced the highest expression of all maturation markers analyzed on BMDCs. The 
surface expression of these activation markers was however significantly decreased in BMDCs 
incubated with C. bracarensis upon Dectin-1 blockage (Figure 15 A and B). Blocking Dectin-1 had 
no marked effect on the expression of any of the markers analyzed in response to C. glabrata or S. 
cerevisiae. Curiously, dectin-1 blockage led to the increased expression of CD80 and CD86 on C. 
albicans-infected BMDCs  (Figure 15 A), 
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Figure 15: Yeast-induced BMDCs maturation/activation. BMDCs were incubated with viable yeast 
cells at a MOI of 1:2 (1 DC: 2 yeast cells) for 24h. To block dectin-1 signaling, anti-mouse Dectin-1 mAb 
(3µg/ml) was added 1 hour prior to infection. To analyze surface activation markers, cells were collected 
and blocked with FcBlock and stained with anti-CD11c-FITC conjugated, anti-MHC classII-Percp conjugated, 
anti-CD80-PE conjugated, and anti-CD86-PE-Cy7 conjugated, and analyzed by FACS. Results are from a 
single experiment set in duplicate. Bars correspond to means plus SD. B- Representative examples of 
histogram overlays of each activation marker analyzed on non-stimulated BMDCs (grey) and on BMDCs 
incubated with C. bracarensis without (black) or with Dectin-1 blockage (red). Bars correspond to means 
plus SD. Unpaired two-tailed t-test was performed to compare, within each species. C. bracarensis n=1 C. 
glabrata n=1; S. cerevisiae n=1 (*P<0,05; ** P<0,01; *** P<0,001, ****P<0,0001). 
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7. Early inflammatory response to C. glabrata and C. bracarensis 
intraperitoneal infection  
 
Neutrophils play a crucial role in controlling and clearing fungal infection. Human 
polymorphonuclear neutrophils are one of the first immune cells recruited to an infection site. 
These cells efficiently engulf and kill microbes (Sampaio et al., 2010).   
The early inflammatory response to C. bracarensis and C. glabrata was evaluated in BALB/c mice 
6 and 72h after intraperitoneal (i.p.) infection with 1×107 yeast cells. The percentage and also 
numbers of neutrophils, inflammatory monocytes, and macrophages recruited into the peritoneal 
cavity of mice infected was assessed by flow citometry using the markers CD11b, Gr-1 (Ly6 C and 
Ly6 G), and F4/80. Neutrophils were defined as CD11bhiGr-1+F4/80-, inflammatory monocytes 
were CD11b+Gr-1+F4/80+, and macrophages were gated as CD11b+Gr-1-F4/80+ (Taylor et al., 
2003). 
As expected, higher recruitment of neutrophils into the peritoneal cavity was observed in both 
infected mouse groups, comparatively to non-infected controls, 6h after infection. However, similar 
percentages and numbers of neutrophils were observed in both infected mouse groups (Figure 16).  
Likewise, 72 h upon infection, the percentage and numbers of inflammatory monocyte in the 
peritoneal exudates of non-infected were significantly lower than those of infected mouse groups, 
while no differences could be observed between infected mouse groups (Figure 16). Conversely, 
the percentage and also numbers of macrophages in non-infected mice were higher than those of 
infected counterparts 6 h upon challenge, but 72 h after infection, although the percentage of 
recruited macrophages was significantly higher in the peritoneal cavity of non-infected mice, the 
total number of these leucocytes was lower than those of infected mice. Once again, no differences 
in percentage or number of macrophages in the peritoneal exudates of either C. glabrata or C. 
bracarensis infected mice were observed (Figure 16).         
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Figure 16: Early intraperitoneal inflammatory response to C. bracarensis and C. glabrata. 
Recruitment of neutrophils, inflammatory monocytes and macrophages into the peritoneal cavity 6 and 72 h 
after i.p. infection of BALB/c mice with 1×107 C. bracarensis or C. glabrata cells. Bars correspond to 
means plus SD. One-way ANOVA with Bonferroni post-Hoc test was performed to compare, within each 
species. PBS n=2; C. bracarensis n=5 (6 h; pooled data from 2 independent experiments) and n=2 (72 h); 
C. glabrata n=5 (6 h; pooled data from 2 independent experiments) and n=2 (72 h) (*P<0,05; ** P<0,01; 
*** P<0,001, ****P<0,0001). 
 
 
Altogether these results highlight differences in cell wall composition/structure among C. glabrata, 
C. bracarensis, and S. cerevisiae that might account for the differential interaction of these yeasts 
with the host. 
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C. glabrata is an important human fungal pathogen (Richardson et al., 2008; Schwarzmuller et al., 
2014) and since 2004, when its genome was released and annotated, its comparison to S. 
cerevisiae has served to discuss possible genomic and metabolic features related to the pathogenic 
nature of the former species (Dujon et al., 2004; Gabaldón et al., 2013). Recently however, C. 
bracarensis was found to be the closest species to C. glabrata, and its study could be important in 
the clarification of infection strategies of this important pathogen.  
The analysis of virulence factors has an important role in the study of pathogens and their 
strategies of infection. However, most of the virulence attributes of the successful pathogen C. 
albicans are absent in C. glabrata (Kaur et al., 2005). Here, the inability of C. glabrata to produce 
Sap or hyphae was confirmed. Moreover, C. bracarensis strains also failed to produce Sap and to 
filament. However, recently it was reported that C. bracarensis NCYC 3133 had some proteolytic 
activity (Moreira et al., 2015). In the present analysis, C. bracarensis NCYC 3133 did not have 
extracellular proteolytic activity, and these disparities could be associated with differences in the 
experimental conditions. Until now, no episodes of hypha formation in C. glabrata and C. 
bracarensis were reported, although Odds and co-workers in 1997, and also Csank and Haynes in 
2000 reported pseudohypha formation in C. glabrata. In accordance with the results presented 
here, very recently, Moreira and co-workers (2015) reported the absence of filamentation in C. 
bracarensis strains cultured in RPMI medium with 10% serum. Despite the lack of some of the 
most important virulence characteristic of C. albicans, C. glabrata and also C. bracarensis seam to 
be capable of establishing successful infections (Rai et al., 2012).  
Several studies indicated that stress responses have diverged in order to generate more robust 
responses in Candida, when compared with the model yeast Saccharomyces cerevisiae (reviewed 
in Quinn and Brown, 2007). For example, fungal pathogens have evolved mechanisms to mount 
robust oxidative stress responses in order to resist the high levels of ROS generated by phagocytic 
cells. As all yeast strains used in this study grew without visible limitations in the presense of H2O2, 
it would be important to repeat this experimental assay with higher concentrations of H2O2 to verify 
if this pattern of resistance was maintained.  
Also, treatment with cell wall-perturbing agents elicits in yeasts a cellular survival response known 
as "compensatory mechanism" that leads to an increase in the amount of β-glucan and chitin, to 
the production of several cell wall proteins, and to changes in the cross-linking between cell wall 
polymers (Arias et al., 2011). Here is shown that C. glabrata, in opposition to C. bracarensis and S. 
cerevisiae, is in general more resistant to cell wall stress agents. C. bracarensis and S. cerevisiae 
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showed here high susceptibility to SDS, a recognized indicator of cell wall integrity (Turmachev et 
al., 1994) due to its capacity to disrupt and solubilize the plasma membrane. On the opposite, C. 
glabrata presented almost no susceptibility to SDS. Lagorce et al., 2003 suggested that increased 
susceptibility to SDS could be associated with a leaky cell wall surface, probably due to an 
increased porosity in the mannan layer. C. bracarensis presented a cell wall relative porosity 
almost 15 times higher than C. glabrata, S. cerevisiae, and C. albicans, as evaluated by using a 
polycation-induced leakage assay of UV-absorving compounds. This increased cell wall porosity is 
in accordance with the high susceptibility to SDS found in this species. Moreover, Cutler in 2001 
proposed cell wall transient gaps in the mannan layer as the best hypothesis to explain yeast cell 
wall permeability. Indeed, it has been demonstrated that the N-linked mannans are inversely 
associated with cell-wall porosity in yeasts, for example, cell wall porosity decreases as the yeast 
cells enter stationary growth, which correlates with increasing content of N-linked mannan (De 
Nobel et al., 1990; Cutler, 2001). However, this explanation cannot justify the susceptibility of S. 
cerevisiae to SDS, since this species had relative cell wall porosity similar to that of C. glabrata. 
Another hypothesis would be related with β-glucan cell wall content, since in the presence of SDS 
the content of β-1,3-glucan can be dramatically reduced, affecting the permeability and osmotic 
balance of the cell wall (Hong et al., 1994; Coca et al., 2000). Given that C. bracarensis presented 
higher cell wall molecular percentage of β-1,3-glucans than C. glabrata and S. cerevisiae, this 
could also be a plausible explanation for the high susceptibility of C. bracarensis to SDS. Yet, this 
hypothesis also cannot support with the high susceptibility of S. cerevisiae to SDS, since this 
species had a β-1,3-glucan content similar to that of C. glabrata.  
All yeast species tested in this study, S. cerevisiae in particular, demonstrated low ability to grow in 
presence of caffeine. C. glabrata was nevertheless more resistant than the other two species at 
37° C. Caffeine is currently used as a phenotypic criterion to evaluate the function of the cell wall 
integrity pathway due to the fact that most of the mutants defective in components of cell wall 
integrity pathway are caffeine-sensitive (Kuranda et al., 2006). 
CFW and congo red are cell wall perturbing agents that bind chitin and affect its assembly within 
the cell wall, which results in weakening of the cell wall (Roncero and Duran, 1985; Ram et al., 
2004). Aside from affecting chitin assembly, congo red also alters glucan synthesis assembly 
(Daher et al., 2011). Once again, C. glabrata was the most resistant species and did not present 
susceptibility to these cell wall stress agents. C. bracarensis and S. cerevisiae were more affected 
by these stressors at 37° C. Curiously, hypersensitivity to CFW has been correlated with an 
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increase in the cell wall chitin content (He et al., 2010), even though synthesis of chitin is a 
general compensatory mechanism to strengthen the cell wall. 
Caspofungin, the most used echinochandin in clinical practice (Rueda et al., 2014), interferes with 
cell wall biosynthesis by inhibition of β-1,3-glucan synthase (Eschenauer et al., 2007; Beese-Sims 
et al., 2012). All species demonstrated susceptibility to caspofungin, however, the highest 
susceptibility to caspofungin was observed in C. bracarensis grown at 30° C and in S. cerevisiae at 
37°C.  While the increased susceptibility of S. cerevisiae to caspofungin at 37°C could be 
attributed to the combination of a cell wall stressor and high temperature (the optimal temperature 
of this species is 30° C), no suitable explanation could be found for the increased susceptibility of 
C. bracarensis at 30° C. C. glabrata is often referred for its resistance to several antifungal drugs, 
namely azoles, and it was also reported that C. glabrata could rapidly develop resistance to 
echinocandins, even during short treatment periods (Perlin, 2014; Domán et al., 2015). The most 
usual reason for caspofungin resistance is related with the chitin content, since high chitin content 
confers reduced susceptibility while low chitin content confers hypersensitivity (Plaine et al., 2008). 
Altogether these results suggest the existence of disparities in cell wall composition/structure 
among the three species. Whether C. glabrata, C. bracarensis, and S. cerevisiae have different 
chitin contents, and if and how cell wall stress agents affect this cell wall component proportion, 
remains to be clarified. Nevertheless, C. glabrata was undoubtedly more resistant to a variety of 
cell wall stress agents, which might account for its success as a pathogen.  
The cell wall also mediates the initial physical interaction between the pathogen and the host 
(Chaffin et al., 1998) and different cell wall structures lead to different immunological responses 
(Lewis et al., 2012). The identity of the fungal cell wall ligands that mediate the initial recognition 
event during host-fungus interaction remains unclear, and several conflicts in the literature about 
contributions of fungal cell wall components to host recognition and phagocytosis can be found 
(Keepler-Ross et al., 2010). In this work, we demonstrated that in all described experimental 
conditions C. glabrata strains were more phagocytosed than C. bracarensis and S. cerevisiae 
strains. C. glabrata has already been reported to be more efficiently internalized by macrophages 
in vitro than S. cerevisiae and C. albicans (Keppler-Ross et al., 2010; Seider et al., 2014), thus, as 
already suggested, avoidance of phagocytosis is less likely to represent an immune evasion 
mechanism of C. glabrata (Brunke and Hube 2013). Keppler-Ross et al. (2010) have indicated cell 
wall mannan, rather than -glucan or chitin, as a key ligand for recognition of C. glabrata and C. 
albicans. Moreover, these authors defended that dectin-1-activation only occurs after the initial 
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recognition of mannan or mannosylated proteins in murine macrophages, in contradiction to what 
has been stated in other studies (Herre et al., 2004; Mckenzie et al., 2010). Higher 
mannose/glucose ratio in C. glabrata was made responsible for the higher rates of phagocytosis by 
macrophages when compared with C. albicans (Groot et al., 2008). Such an explanation would 
perfectly suit the differences found in C. glabrata vs C. bracarensis phagocytosis, but fail to explain 
why S. cerevisiae, which had a cell wall mannose/glucose ratio similar to that of C. glabrata, was 
so poorly internalized. No differences in yeast phagocytosis were found upon blocking mannan 
receptor with soluble mannans, though this effect could be anticipated in RAW 246.7 
macrophages, which were reported as not expressing this PRR (Li et al., 2010). On the opposite, 
pre-incubation with laminarin and with anti-Dectin-1 mAb induced a decrease in the phagocytosis 
rates of C. glabrata, S. cerevisiae, and C. albicans, but not of C. bracarensis. Although these 
results indicate that the content of β-1,3-glucan was not directly associated with the phagocytosis 
rates, the reason for the effect in C. glabrata and S. cerevisiae phagocytosis is somewhat 
ambiguous. On the one hand, RAW 246.7 macrophages express low levels of Dectin-1 (Li et al., 
2010), and on the other hand, C. glabrata and S. cerevisiae had the lowest β-1,3-glucan exposure. 
Whether laminarin and anti-Dectin-1 mAb could be inhibiting other internalization routes would be 
worth clarifying. 
Upon interaction with pathogens, phagocytes rapidly produce ROS to destroy invading microbes 
(Frohner et al., 2009). However, several pathogens have developed strategies to evade this 
microcidal mechanism. Namely, C. albicans and C. glabrata, but not S. cerevisiae, can actively 
suppress ROS production in a murine macrophage cell line (Wellington et al., 2009). The 
recognition of components of the fungal cell wall is needed for ROS production and Candida 
viability is needed for the suppression effect. Here, it is shown that not only viable C. glabrata and 
C. bracarensis could suppress ROS production, but unexpectedly, S. cerevisiae could reduce ROS 
production to more than half. Heat killing of Candida cells, resulting in increased exposure of cell 
wall β-1,3-glucan, which is highly immunostimulatory, is charged for the increase in ROS 
production when macrophages are stimulated with HK comparatively to viable yeasts (Wellington et 
al., 2009). This effect is most probably through phagocyte receptor Dectin-1 signalling, which 
besides being a phagocytic receptor, also leads to ROS and cytokine production (Ifrim, 2014; 
Seider et al, 2014; Netea et al., 2015). The similar ROS production by macrophages exposed to C. 
glabrata and C. bracarensis, though C. glabrata was significantly more phagocytosed than C. 
bracarensis, could be a result of higher β-1,3-glucan accessibility in C. bracarensis, and 
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consequently higher recognition by Dectin-1 and higher ROS production. Also, a much higher β-
1,3-glucan exposure in S. cerevisiae upon heat killing in this study, related to the one obtained in 
the Wellington and co-workers study, could account to the observed elevated ROS production. 
Alternatively, this suppressive effect on ROS production could be strain dependent, since the S. 
cerevisiae strains used here could suppress considerably the induction of this microcidal 
mechanism. 
C. bracarensis presented a significantly higher 1,3-glucose content and higher β-1,3-glucan 
exposure than C. glabrata and S. cerevisiae. Several cell wall mutants with increased exposure of 
β-1-3-glucans exhibited increased recognition by phagocytic cells, resulting in increased 
phagocytosis and production of cytokines by macrophages, thus inducing a strong response by the 
innate immune system (Davis et al., 2014). The higher content and also exposure of β-1-3-glucan 
in C. bracarensis, might have accounted for the increased levels of proinflammatory cytokines 
induced by this species in BMDCs and BMMs due, in part, to the immune recognition through 
Dectin-1, since the recognition of this cell wall component leads to the induction of 
proinflammatory cytokines (Netea et al., 2010). Intact cells of S. cerevisiae and C. albicans have 
low reactivity with Dectin-1 receptor (Seider et al., 2014), however, when β-glucans were more 
exposed, binding of Dectin-1 facilitated recognition and elicited immune cell activation and 
production of cytokines such as IL-23 and TNF-α. The more exposed β-1,3-glucans in the cell wall 
of C. bracarensis could thus be mediating such an effect in BMDCs and BMMs. Why dectin-1 
blockage affected negatively BMDCs maturation and cytokine production by both BMDCs and 
BMMs but not phagocytosis by murine macrophages is somewhat puzzling. Nevertheless, these 
processes of the innate immune response are not necessarily positively correlated. It is already 
known that Dectin-1-mediated (TLR2-dependent) cytokine production in response to β-glucans can 
occur at the cell surface without the need for phagocytosis (Brown et al., 2003).!Dectin-1 mediated 
phagocytic clearance of fungal particles and induction of transcription of innate response genes are 
linked but, curiously, Dectin-1 signaling for inflammation is attenuated by phagocytosis, because 
blocking Dectin-1 ligand-dependent internalization on phagocytic cells leads the production of high 
levels of pro-inflammatory cytokines (Hernanz-Falcón et al., 2009). 
Given the differences in cell wall components between C. glabrata and C. bracarensis, a distinct 
recruitment of inflammatory leukocytes into the peritoneal cavity of mice i.p. infected with these 
two yeast species could be expected. Yet, no such differences could be observed regarding 
neutrophils, inflammatory monocytes, and macrophages recruitment. It would be interesting to 
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evaluate if, despite similar leukocyte recruitment, a distinct profile of cytokines and chemokines 
was being induced, resulting in a later disparate immune response to the two yeast species. 
Altogether these results support the hypothesis that C. bracarensis, due to more exposed cell wall 
β-1-3-glucans, facilitate yeast recognition by the C-type lectin Dectin-1, which would be in 
agreement with the observed increased IL-23 and also TNF-α elicited in response to this species 
that was reduced upon Dectin-1 blockage. The higher accessibility to C. bracarensis β-1,3-glucans 
could in part be due to the higher porosity of the cell wall of this yeast species. A strong Dectin-1-
mediated proinflammatory response by the host innate immune cells to C. bracarensis could thus 
contribute to a faster elimination of this pathogen. Although these results do not by themselves 
fully elucidate the disparate incidence of C. glabrata vs C. bracarensis, they nevertheless contribute 
to better understand the differences on the interaction of these two related species with the host. 
 
 
It would be interesting to evaluate in the future if C. bracarensis would also lead to a marked 
proinflammatory response in cells of the human innate immune response. Also, if this yeast 
species could share C. glabrata’s ability to interfere with the phagosome maturation and to survive 
within macrophages would be worth studying. Finally, a deeper characterization of the cell wall of 
these sibling species, namely by transmission electronic microscopy, and a comparative study of 
genes involved in cell wall synthesis/assembly could also contribute to clarify the disparate 
incidence of infection of these yeasts. 
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